sign in sign up
<<
Home , Caffeine citrate, Guanidine, Prasugrel, Ticagrelor

Prescription and Over-the-Counter Drug Product List 40TH EDITION Cumulative Supplement Number 09 : September 2020 ADDITIONS/DELETIONS FOR PRODUCT LIST

ACETAMINOPHEN; BUTALBITAL; TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA STRIDES PHARMA 325MG;50MG;40MG A 203647 001 Sep 21, 2020 Sep NEWA

ACETAMINOPHEN; PHOSPHATE SOLUTION;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> AA WOCKHARDT BIO AG 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC >A> @ 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> AA NOSTRUM LABS INC 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >A> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >A> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN >D> AA TEVA 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >D> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >D> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN

ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >A> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >A> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN >D> AA VINTAGE PHARMS 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >A> @ 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >D> AA 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >A> @ 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >D> AA 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >A> @ 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >D> @ XIROMED 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >D> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >D> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN >D> @ XIROMED 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN

ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >A> AB MICRO LABS LTD INDIA 500MG A 207401 001 Oct 01, 2020 Sep NEWA TABLET;ORAL ACETAZOLAMIDE >A> MANKIND PHARMA 125MG A 214282 001 Oct 07, 2020 Sep NEWA >A> 250MG A 214282 002 Oct 07, 2020 Sep NEWA

ACYCLOVIR CAPSULE;ORAL ACYCLOVIR >A> AB YILING 200MG A 212173 001 Sep 14, 2020 Sep NEWA OINTMENT;TOPICAL ACYCLOVIR >A> AB ANDA REPOSITORY 5% A 206437 001 Jul 31, 2017 Sep CAHN >D> AB TOLMAR 5% A 206437 001 Jul 31, 2017 Sep CAHN

ALBUTEROL SULFATE AEROSOL, METERED;INHALATION ALBUTEROL SULFATE >A> AB2 LUPIN EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN >D> AB2 LUPIN ATLANTIS EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN

Page 1 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMANTADINE HYDROCHLORIDE CAPSULE;ORAL AMANTADINE HYDROCHLORIDE >D> AB INVATECH 100MG A 210129 001 Mar 02, 2020 Sep CAHN >A> AB NOVELGENIX THERAPS 100MG A 210129 001 Mar 02, 2020 Sep CAHN TABLET, EXTENDED RELEASE;ORAL OSMOLEX ER >D> + OSMOTICA PHARM EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC >A> + @ EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC TABLET;ORAL AMANTADINE HYDROCHLORIDE >D> AB INVATECH 100MG A 210215 001 Mar 10, 2020 Sep CAHN >A> AB NOVELGENIX THERAPS 100MG A 210215 001 Mar 10, 2020 Sep CAHN

AMILORIDE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> AB ANDA REPOSITORY 5MG A 204180 001 Aug 07, 2015 Sep CAHN >D> AB WINDLAS HLTHCARE 5MG A 204180 001 Aug 07, 2015 Sep CAHN

AMISULPRIDE SOLUTION;INTRAVENOUS BARHEMSYS >A> +! ACACIA 10MG/4ML (2.5MG/ML) N 209510 002 Sep 01, 2020 Sep NEWA

AMLODIPINE BESYLATE TABLET;ORAL AMLODIPINE BESYLATE >D> AB HEBEI CHANGSHAN EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >D> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >D> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN >D> AB HIKMA PHARMS EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >A> @ EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >D> AB EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >A> @ EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >D> AB EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC >A> @ EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC >A> AB YILING EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >A> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >A> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN

AMOXICILLIN; CLAVULANATE POTASSIUM TABLET, EXTENDED RELEASE;ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM >D> AB SANDOZ 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >A> AB ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >A> ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CTEC >D> AUGMENTIN XR >D> AB +! NEOPHARMA 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC >A> + @ 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC

AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE >A> AA NOVAST LABS 5MG A 213763 001 Aug 24, 2020 Sep CAHN >A> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN >D> AA RICONPHARMA LLC 5MG A 213763 001 Aug 24, 2020 Sep CAHN >D> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN

ANASTROZOLE TABLET;ORAL >D> AB HIKMA 1MG A 078485 001 Jun 28, 2010 Sep DISC >A> @ 1MG A 078485 001 Jun 28, 2010 Sep DISC

Page 2 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

APIXABAN TABLET;ORAL >A> AB INDOCO 2.5MG A 209898 001 Sep 11, 2020 Sep NEWA >A> AB 5MG A 209898 002 Sep 11, 2020 Sep NEWA ELIQUIS >D> + BRISTOL MYERS SQUIBB 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC >A> AB + 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC >D> +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC >A> AB +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC

ASPIRIN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, AND CAFFEINE >D> AA ! HIKMA INTL PHARMS 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >A> @ 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >D> AA STRIDES PHARMA 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS >A> AA ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS >A> ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CTEC

ATROPINE SULFATE SOLUTION;INTRAVENOUS ATROPINE SULFATE >A> +! ACCORD HLTHCARE 0.4MG/ML (0.4MG/ML) N 214652 001 Sep 29, 2020 Sep NEWA >A> +! 1MG/ML (1MG/ML) N 214652 002 Sep 29, 2020 Sep NEWA >D> +! HOSPIRA 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG >A> AA +! 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG >A> AA INTL SYS 1MG/10ML (0.1MG/ML) A 212461 001 Oct 05, 2020 Sep NEWA

ATROPINE SULFATE; HYDROCHLORIDE TABLET;ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE >A> AA SPECGX LLC 2.5MG;0.025MG A 213335 001 Oct 06, 2020 Sep NEWA LOMOTIL >D> AA +! GD SEARLE LLC 0.025MG;2.5MG N 012462 001 Sep 15, 1960 Sep CAHN >A> AA +! PFIZER 0.025MG;2.5MG N 012462 001 Sep 15, 1960 Sep CAHN

AZACITIDINE >A> TABLET;ORAL >A> ONUREG >A> + CELGENE CORP 200MG N 214120 001 Sep 01, 2020 Sep NEWA >A> +! 300MG N 214120 002 Sep 01, 2020 Sep NEWA

AZELAIC ACID AEROSOL, FOAM;TOPICAL >A> AZELAIC ACID >A> AB TEVA PHARMS USA 15% A 210928 001 Oct 07, 2020 Sep NFTG FINACEA >D> +! LEO PHARMA AS 15% N 207071 001 Jul 29, 2015 Sep CFTG >A> AB +! 15% N 207071 001 Jul 29, 2015 Sep CFTG

BENAZEPRIL HYDROCHLORIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE >A> AB ANNORA PHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN >A> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN >A> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN >A> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN >D> AB COREPHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN >D> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN >D> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN >D> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN

BETAMETHASONE DIPROPIONATE LOTION;TOPICAL DIPROPIONATE >A> @ INVATECH EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN >D> @ PHARMADERM EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN

Page 3 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE SUSPENSION;TOPICAL CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE >A> AB PERRIGO UK FINCO 0.064%;0.005% A 212367 001 Sep 11, 2020 Sep NEWA

BETHANECHOL CHLORIDE TABLET;ORAL BETHANECHOL CHLORIDE >A> AA DISCOVERY THERAP 5MG A 040728 002 Oct 26, 2007 Sep CAHN >A> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >A> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >A> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN >D> AA ECI PHARMS LLC 5MG A 040728 002 Oct 26, 2007 Sep CAHN >D> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >D> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >D> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN

BIVALIRUDIN INJECTABLE;INTRAVENOUS >D> AP CIPLA 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN >A> AP HONG KONG 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN

BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP;ORAL MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE >A> AA BRECKENRIDGE 2MG/5ML;10MG/5ML;30MG/5ML A 203997 001 Sep 30, 2020 Sep NEWA >A> AA EYWA 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN >D> AA WES PHARMA INC 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN

BUDESONIDE TABLET, EXTENDED RELEASE;ORAL >A> AB MYLAN 9MG A 208851 001 Sep 17, 2020 Sep NEWA

BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >A> AB3 ADAPTIS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >A> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN >D> AB3 GRAVITI PHARMS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >D> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN

CAFFEINE CITRATE SOLUTION;INTRAVENOUS >D> AP SUN PHARM EQ 30MG BASE/3ML (EQ 10MG A 090077 001 Sep 30, 2009 Sep DISC BASE/ML) >A> @ EQ 30MG BASE/3ML (EQ 10MG A 090077 001 Sep 30, 2009 Sep DISC BASE/ML)

CAFFEINE; ERGOTAMINE TARTRATE TABLET;ORAL ERGOTAMINE TARTRATE AND CAFFEINE >D> AA HIKMA INTL PHARMS 100MG;1MG A 040510 001 Sep 17, 2004 Sep DISC >A> @ 100MG;1MG A 040510 001 Sep 17, 2004 Sep DISC

CAPTOPRIL TABLET;ORAL CAPTOPRIL >A> @ ANNORA PHARMA 12.5MG A 074737 001 Oct 28, 1998 Sep CAHN >A> @ 25MG A 074737 002 Oct 28, 1998 Sep CAHN >A> @ 50MG A 074737 003 Oct 28, 1998 Sep CAHN >A> @ 100MG A 074737 004 Oct 28, 1998 Sep CAHN >D> @ COREPHARMA 12.5MG A 074737 001 Oct 28, 1998 Sep CAHN >D> @ 25MG A 074737 002 Oct 28, 1998 Sep CAHN >D> @ 50MG A 074737 003 Oct 28, 1998 Sep CAHN >D> @ 100MG A 074737 004 Oct 28, 1998 Sep CAHN

Page 4 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CARBIDOPA; ENTACAPONE; LEVODOPA TABLET;ORAL CARBIDOPA, LEVODOPA AND ENTACAPONE >D> AB MYLAN 12.5MG;200MG;50MG A 203424 001 Aug 13, 2020 Sep DISC >A> @ 12.5MG;200MG;50MG A 203424 001 Aug 13, 2020 Sep DISC >D> AB 18.75MG;200MG;75MG A 203424 002 Aug 13, 2020 Sep DISC >A> @ 18.75MG;200MG;75MG A 203424 002 Aug 13, 2020 Sep DISC >D> AB 25MG;200MG;100MG A 203424 003 Aug 13, 2020 Sep DISC >A> @ 25MG;200MG;100MG A 203424 003 Aug 13, 2020 Sep DISC >D> AB 31.25MG;200MG;125MG A 203424 004 Aug 13, 2020 Sep DISC >A> @ 31.25MG;200MG;125MG A 203424 004 Aug 13, 2020 Sep DISC >D> AB 37.5MG;200MG;150MG A 203424 005 Aug 13, 2020 Sep DISC >A> @ 37.5MG;200MG;150MG A 203424 005 Aug 13, 2020 Sep DISC >D> AB 50MG;200MG;200MG A 203424 006 Aug 13, 2020 Sep DISC >A> @ 50MG;200MG;200MG A 203424 006 Aug 13, 2020 Sep DISC STALEVO 125 >D> AB + ORION PHARMA 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Sep CTEC >A> + 31.25MG;200MG;125MG N 021485 006 Aug 29, 2008 Sep CTEC STALEVO 200 >D> AB +! ORION PHARMA 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Sep CTEC >A> +! 50MG;200MG;200MG N 021485 004 Aug 02, 2007 Sep CTEC STALEVO 50 >D> AB +! ORION PHARMA 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Sep CTEC >A> +! 12.5MG;200MG;50MG N 021485 001 Jun 11, 2003 Sep CTEC STALEVO 75 >D> AB + ORION PHARMA 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Sep CTEC >A> + 18.75MG;200MG;75MG N 021485 005 Aug 29, 2008 Sep CTEC

CARBOPLATIN INJECTABLE;INTRAVENOUS CARBOPLATIN >D> @ EUGIA PHARMA 50MG/5ML (10MG/ML) A 205487 001 Mar 28, 2016 Sep CMFD >A> AP 50MG/5ML (10MG/ML) A 205487 001 Mar 28, 2016 Sep CMFD >D> @ 150MG/15ML (10MG/ML) A 205487 002 Mar 28, 2016 Sep CMFD >A> AP 150MG/15ML (10MG/ML) A 205487 002 Mar 28, 2016 Sep CMFD >D> @ 450MG/45ML (10MG/ML) A 205487 003 Mar 28, 2016 Sep CMFD >A> AP 450MG/45ML (10MG/ML) A 205487 003 Mar 28, 2016 Sep CMFD >D> AP INGENUS PHARMS LLC 50MG/5ML (10MG/ML) A 208487 001 Apr 26, 2017 Sep CAHN >D> AP 150MG/15ML (10MG/ML) A 208487 002 Apr 26, 2017 Sep CAHN >D> AP 450MG/45ML (10MG/ML) A 208487 003 Apr 26, 2017 Sep CAHN >D> AP 600MG/60ML (10MG/ML) A 208487 004 Apr 26, 2017 Sep CAHN >A> AP NOVAST LABS 50MG/5ML (10MG/ML) A 208487 001 Apr 26, 2017 Sep CAHN >A> AP 150MG/15ML (10MG/ML) A 208487 002 Apr 26, 2017 Sep CAHN >A> AP 450MG/45ML (10MG/ML) A 208487 003 Apr 26, 2017 Sep CAHN >A> AP 600MG/60ML (10MG/ML) A 208487 004 Apr 26, 2017 Sep CAHN

CARFILZOMIB POWDER;INTRAVENOUS CARFILZOMIB >D> AP APOTEX 30MG/VIAL A 211185 001 Mar 20, 2020 Sep DISC >A> @ 30MG/VIAL A 211185 001 Mar 20, 2020 Sep DISC >D> AP 60MG/VIAL A 209425 001 Mar 16, 2020 Sep DISC >A> @ 60MG/VIAL A 209425 001 Mar 16, 2020 Sep DISC KYPROLIS >D> AP + ONYX THERAP 30MG/VIAL N 202714 002 Jun 03, 2016 Sep CTEC >A> + 30MG/VIAL N 202714 002 Jun 03, 2016 Sep CTEC

CARISOPRODOL TABLET;ORAL CARISOPRODOL >A> AA NOSTRUM LABS INC 350MG A 207237 002 Sep 21, 2020 Sep NEWA

CEFIXIME CAPSULE;ORAL CEFIXIME >D> AB ALKEM LABS LTD 400MG A 210574 001 Oct 09, 2018 Sep CTEC >A> 400MG A 210574 001 Oct 09, 2018 Sep CTEC >A> ! 400MG A 210574 001 Oct 09, 2018 Sep CHRS

Page 5 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CEFIXIME CAPSULE;ORAL SUPRAX >D> AB +! LUPIN LTD 400MG N 203195 001 Jun 01, 2012 Sep DISC >A> + @ 400MG N 203195 001 Jun 01, 2012 Sep DISC

CELECOXIB CAPSULE;ORAL CELECOXIB >A> @ YILING 50MG A 211412 001 Mar 06, 2020 Sep DISC >A> @ 100MG A 211412 002 Mar 06, 2020 Sep DISC >A> @ 200MG A 211412 003 Mar 06, 2020 Sep DISC >A> @ 400MG A 211412 004 Mar 06, 2020 Sep DISC >D> AB YILING PHARM LTD 50MG A 211412 001 Mar 06, 2020 Sep DISC >D> AB 100MG A 211412 002 Mar 06, 2020 Sep DISC >D> AB 200MG A 211412 003 Mar 06, 2020 Sep DISC >D> AB 400MG A 211412 004 Mar 06, 2020 Sep DISC SOLUTION;ORAL >D> ELYXYB >D> +! DR REDDYS 25MG/ML N 212157 001 May 05, 2020 Sep DISC >A> + @ 25MG/ML N 212157 001 May 05, 2020 Sep DISC

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE CAPSULE;ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE >A> AB NUVO PHARMS INC 5MG;2.5MG A 211421 001 Jul 07, 2020 Sep CAHN >D> AB SUNRISE PHARM INC 5MG;2.5MG A 211421 001 Jul 07, 2020 Sep CAHN

CHLOROQUINE PHOSPHATE TABLET;ORAL CHLOROQUINE PHOSPHATE >D> AA HIKMA PHARMS 500MG A 083082 002 Sep 17, 1999 Sep DISC >A> @ 500MG A 083082 002 Sep 17, 1999 Sep DISC

CHLORZOXAZONE TABLET;ORAL CHLORZOXAZONE >A> AB I3 PHARMS 375MG A 212053 001 Sep 14, 2020 Sep NEWA >A> AB 750MG A 212053 002 Sep 14, 2020 Sep NEWA

CHOLESTYRAMINE POWDER;ORAL LOCHOLEST >D> @ ALLIED EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Sep CAHN >D> @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Sep CAHN >A> @ CHARTWELL RX EQ 4GM RESIN/PACKET A 074561 001 Aug 15, 1996 Sep CAHN >A> @ EQ 4GM RESIN/SCOOPFUL A 074561 002 Aug 15, 1996 Sep CAHN

CIMETIDINE TABLET;ORAL >D> AB HIKMA 200MG A 074890 001 Dec 18, 1998 Sep DISC >A> @ 200MG A 074890 001 Dec 18, 1998 Sep DISC >D> AB 300MG A 074890 002 Dec 18, 1998 Sep DISC >A> @ 300MG A 074890 002 Dec 18, 1998 Sep DISC >D> AB 400MG A 074890 003 Dec 18, 1998 Sep DISC >A> @ 400MG A 074890 003 Dec 18, 1998 Sep DISC >D> AB 800MG A 074890 004 Dec 18, 1998 Sep DISC >A> @ 800MG A 074890 004 Dec 18, 1998 Sep DISC

CINACALCET HYDROCHLORIDE TABLET;ORAL CINACALCET HYDROCHLORIDE >A> AB DR REDDYS EQ 30MG BASE A 208368 001 Sep 18, 2020 Sep NEWA >A> AB EQ 60MG BASE A 208368 002 Sep 18, 2020 Sep NEWA >A> AB EQ 90MG BASE A 208368 003 Sep 18, 2020 Sep NEWA >A> AB HETERO LABS LTD V EQ 30MG BASE A 209403 001 Oct 07, 2020 Sep NEWA >A> AB EQ 60MG BASE A 209403 002 Oct 07, 2020 Sep NEWA >A> AB EQ 90MG BASE A 209403 003 Oct 07, 2020 Sep NEWA

Page 6 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CLARITHROMYCIN TABLET;ORAL >D> AB HIKMA 250MG A 065178 002 May 25, 2004 Sep DISC >A> @ 250MG A 065178 002 May 25, 2004 Sep DISC >D> AB 500MG A 065178 001 May 25, 2004 Sep DISC >A> @ 500MG A 065178 001 May 25, 2004 Sep DISC

CLINDAMYCIN PHOSPHATE SOLUTION;TOPICAL CLINDAMYCIN PHOSPHATE >D> AT FOUGERA PHARMS EQ 1% BASE A 065254 001 Feb 14, 2006 Sep DISC >A> @ EQ 1% BASE A 065254 001 Feb 14, 2006 Sep DISC SWAB;TOPICAL CLEOCIN >D> AT + PHARMACIA AND UPJOHN EQ 1% BASE N 050537 002 Feb 22, 1994 Sep CHRS >A> AT +! EQ 1% BASE N 050537 002 Feb 22, 1994 Sep CHRS

CLOBETASOL PROPIONATE SPRAY;TOPICAL CLOBETASOL PROPIONATE >D> @ ALEOR DERMACEUTICALS 0.05% A 211191 001 Oct 02, 2019 Sep CMFD >A> AT 0.05% A 211191 001 Oct 02, 2019 Sep CMFD

CLOFARABINE SOLUTION;INTRAVENOUS CLOFARABINE >D> AP INGENUS PHARMS LLC 20MG/20ML (1MG/ML) A 210270 001 Sep 14, 2018 Sep CAHN >A> AP NOVAST LABS 20MG/20ML (1MG/ML) A 210270 001 Sep 14, 2018 Sep CAHN

CLOMIPRAMINE HYDROCHLORIDE CAPSULE;ORAL CLOMIPRAMINE HYDROCHLORIDE >A> AB AJANTA PHARMA LTD 25MG A 213897 001 Oct 02, 2020 Sep NEWA >A> AB 50MG A 213897 002 Oct 02, 2020 Sep NEWA >A> AB 75MG A 213897 003 Oct 02, 2020 Sep NEWA >D> AB VGYAAN 25MG A 213221 001 Jun 22, 2020 Sep DISC >A> @ 25MG A 213221 001 Jun 22, 2020 Sep DISC >D> AB 50MG A 213221 002 Jun 22, 2020 Sep DISC >A> @ 50MG A 213221 002 Jun 22, 2020 Sep DISC >D> AB 75MG A 213221 003 Jun 22, 2020 Sep DISC >A> @ 75MG A 213221 003 Jun 22, 2020 Sep DISC

CLONIDINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >D> AB MYLAN 0.1MG A 070317 002 Jul 09, 1987 Sep DISC >A> @ 0.1MG A 070317 002 Jul 09, 1987 Sep DISC >D> AB 0.2MG A 070317 003 Jun 09, 1987 Sep DISC >A> @ 0.2MG A 070317 003 Jun 09, 1987 Sep DISC >D> AB 0.3MG A 070317 001 Jun 09, 1987 Sep DISC >A> @ 0.3MG A 070317 001 Jun 09, 1987 Sep DISC

CLOPIDOGREL BISULFATE TABLET;ORAL BISULFATE >A> AB ADAPTIS EQ 75MG BASE A 204359 001 Feb 02, 2017 Sep CAHN >D> AB GRAVITI PHARMS EQ 75MG BASE A 204359 001 Feb 02, 2017 Sep CAHN

>A> DOTATATE CU-64 >A> SOLUTION;INTRAVENOUS >A> DETECTNET >A> +! RADIOMEDIX 4mL (1mCi/ML) N 213227 001 Sep 03, 2020 Sep NEWA

CYANOCOBALAMIN INJECTABLE;INJECTION CYANOCOBALAMIN >A> AP GLAND PHARMA LTD 1MG/ML A 214390 001 Sep 24, 2020 Sep NEWA

Page 7 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CYPROHEPTADINE HYDROCHLORIDE TABLET;ORAL CYPROHEPTADINE HYDROCHLORIDE >D> AA APEX PHARMS INC 4MG A 207783 001 Dec 29, 2016 Sep CAHN >A> AA RISING 4MG A 207783 001 Dec 29, 2016 Sep CAHN

DAPIPRAZOLE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DAPIPRAZOLE HYDROCHLORIDE >D> @ BARADAINA LLC 0.5% A 204902 001 May 30, 2019 Sep CAHN >A> @ WOODWARD 0.5% A 204902 001 May 30, 2019 Sep CAHN

DAPSONE TABLET;ORAL DAPSONE >A> AB RISING 100MG A 207165 001 May 08, 2019 Sep CAHN >D> AB SAI LIFE SCIENCES 100MG A 207165 001 May 08, 2019 Sep CAHN

DESMOPRESSIN ACETATE INJECTABLE;INJECTION DESMOPRESSIN ACETATE >A> AP UBI 0.004MG/ML A 210223 001 Sep 17, 2020 Sep NEWA

DESVENLAFAXINE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE >D> +! ALEMBIC PHARMS LTD 50MG N 204150 001 Mar 04, 2013 Sep CHRS >A> + 50MG N 204150 001 Mar 04, 2013 Sep CHRS

DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL PRISTIQ >D> AB +! PF PRISM CV EQ 50MG BASE N 021992 001 Feb 29, 2008 Sep CHRS >A> AB + EQ 50MG BASE N 021992 001 Feb 29, 2008 Sep CHRS

DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE;INJECTION DEXAMETHASONE SODIUM PHOSPHATE >D> @ AUROBINDO PHARMA LTD EQ 10MG PHOSPHATE/ML A 210967 001 Jun 07, 2019 Sep CMFD >A> AP EQ 10MG PHOSPHATE/ML A 210967 001 Jun 07, 2019 Sep CMFD

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION DEXMEDETOMIDINE HYDROCHLORIDE >D> @ CIPLA EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Sep CAHN BASE/ML) >A> @ HONG KONG EQ 200MCG BASE/2ML (EQ 100MCG A 204843 001 Jan 18, 2019 Sep CAHN BASE/ML) >A> AP PAR STERILE PRODUCTS EQ 200MCG BASE/50ML (EQ 4MCG A 208266 001 Sep 15, 2020 Sep NEWA BASE/ML) >A> AP EQ 400MCG BASE/100ML (EQ 4MCG A 208266 002 Sep 15, 2020 Sep NEWA BASE/ML)

DEXMETHYLPHENIDATE HYDROCHLORIDE TABLET;ORAL DEXMETHYLPHENIDATE HYDROCHLORIDE >D> AB BIONPHARMA INC 5MG A 209754 001 Mar 24, 2020 Sep DISC >A> @ 5MG A 209754 001 Mar 24, 2020 Sep DISC >D> AB 10MG A 209754 002 Mar 24, 2020 Sep DISC >A> @ 10MG A 209754 002 Mar 24, 2020 Sep DISC

DEXTROSE; POTASSIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% >A> AP FRESENIUS KABI USA 5GM/100ML;75MG/100ML A 212346 001 Sep 10, 2020 Sep NEWA DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN CONTAINER >D> + BAXTER HLTHCARE 5GM/100ML;75MG/100ML N 017634 004 Feb 01, 1979 Sep CTEC >A> AP + 5GM/100ML;75MG/100ML N 017634 004 Feb 01, 1979 Sep CTEC DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% >A> AP FRESENIUS KABI USA 5GM/100ML;150MG/100ML A 212346 002 Sep 10, 2020 Sep NEWA

Page 8 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXTROSE; SODIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 5% AND SODIUM CHLORIDE 0.225% >A> AP FRESENIUS KABI USA 5GM/100ML;225MG/100ML A 211221 001 Sep 15, 2020 Sep NFTG DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER >D> +! ICU MEDICAL INC 5GM/100ML;225MG/100ML N 017606 001 Aug 13, 1975 Sep CFTG >A> AP +! 5GM/100ML;225MG/100ML N 017606 001 Aug 13, 1975 Sep CFTG DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;450MG/100ML A 211276 001 Sep 15, 2020 Sep NEWA DEXTROSE 5% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 5GM/100ML;900MG/100ML A 211211 001 Sep 14, 2020 Sep NEWA

DIAZEPAM INJECTABLE;INJECTION DIAZEPAM >D> AP BELOTECA INC 10MG/2ML (5MG/ML) A 210363 001 Mar 18, 2019 Sep CHRS >A> ! 10MG/2ML (5MG/ML) A 210363 001 Mar 18, 2019 Sep CHRS >D> AP ! HOSPIRA 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Sep DISC >A> @ 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Sep DISC

DICLOFENAC POTASSIUM TABLET;ORAL DICLOFENAC POTASSIUM >D> AB AMICI 50MG A 076561 001 Mar 18, 2004 Sep CAHN >A> AB ANDA REPOSITORY 50MG A 076561 001 Mar 18, 2004 Sep CAHN

DICLOFENAC SODIUM SOLUTION;TOPICAL DICLOFENAC SODIUM >A> @ NOVAST LABS 1.5% A 206715 001 Aug 07, 2017 Sep CAHN >D> @ RICONPHARMA LLC 1.5% A 206715 001 Aug 07, 2017 Sep CAHN TABLET, DELAYED RELEASE;ORAL DICLOFENAC SODIUM >D> AB MYLAN PHARMS INC 50MG A 075281 002 Feb 12, 2002 Sep DISC >A> @ 50MG A 075281 002 Feb 12, 2002 Sep DISC >D> AB 75MG A 075281 003 Feb 12, 2002 Sep DISC >A> @ 75MG A 075281 003 Feb 12, 2002 Sep DISC

DIMETHYL FUMARATE CAPSULE, DELAYED RELEASE;ORAL DIMETHYL FUMARATE >A> AB ACCORD HLTHCARE 120MG A 210499 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210499 002 Sep 24, 2020 Sep NEWA >A> AB ALKEM LABS LTD 120MG A 210440 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210440 002 Sep 24, 2020 Sep NEWA >A> AB AMNEAL 120MG A 210402 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210402 002 Sep 24, 2020 Sep NEWA >A> AB CIPLA 120MG A 210305 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210305 002 Sep 24, 2020 Sep NEWA >A> AB GLENMARK PHARMS LTD 120MG A 210309 001 Oct 06, 2020 Sep NEWA >A> AB 240MG A 210309 002 Oct 06, 2020 Sep NEWA >A> AB HETERO LABS LTD III 120MG A 210500 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210500 002 Sep 24, 2020 Sep NEWA >A> AB LUPIN ATLANTIS 120MG A 210226 001 Oct 05, 2020 Sep NEWA >A> AB 240MG A 210226 002 Oct 05, 2020 Sep NEWA >A> AB MSN 120MG A 210460 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210460 002 Sep 24, 2020 Sep NEWA >A> AB ZYDUS PHARMS 120MG A 210538 001 Sep 24, 2020 Sep NEWA >A> AB 240MG A 210538 002 Sep 24, 2020 Sep NEWA

DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION DIPHENHYDRAMINE HYDROCHLORIDE >D> AP HOSPIRA 50MG/ML A 040140 001 Nov 20, 1998 Sep DISC >A> @ 50MG/ML A 040140 001 Nov 20, 1998 Sep DISC

Page 9 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DIVALPROEX SODIUM TABLET, EXTENDED RELEASE;ORAL DIVALPROEX SODIUM >D> @ LUPIN LTD EQ 250MG VALPROIC ACID A 209286 001 Oct 18, 2019 Sep CMFD >A> AB EQ 250MG VALPROIC ACID A 209286 001 Oct 18, 2019 Sep CMFD >D> @ EQ 500MG VALPROIC ACID A 209286 002 Oct 18, 2019 Sep CMFD >A> AB EQ 500MG VALPROIC ACID A 209286 002 Oct 18, 2019 Sep CMFD

DOBUTAMINE HYDROCHLORIDE INJECTABLE;INJECTION DOBUTAMINE HYDROCHLORIDE >D> AP HOSPIRA EQ 12.5MG BASE/ML A 074086 001 Nov 29, 1993 Sep CHRS >A> AP ! EQ 12.5MG BASE/ML A 074086 001 Nov 29, 1993 Sep CHRS >D> AP ! EQ 12.5MG BASE/ML A 074292 001 Feb 16, 1995 Sep DISC >A> @ EQ 12.5MG BASE/ML A 074292 001 Feb 16, 1995 Sep DISC

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >D> @ CIPLA 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Sep CAHN >D> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Sep CAHN >D> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Sep CAHN >A> @ HONG KONG 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Sep CAHN >A> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Sep CAHN >A> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Sep CAHN

DOXERCALCIFEROL CAPSULE;ORAL DOXERCALCIFEROL >A> AB AVET 0.5MCG A 205360 001 Sep 15, 2020 Sep NEWA >A> AB 1MCG A 205360 002 Sep 15, 2020 Sep NEWA >A> AB 2.5MCG A 205360 003 Sep 15, 2020 Sep NEWA

DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION DOXORUBICIN HYDROCHLORIDE >A> AB ZYDUS 20MG/10ML (2MG/ML) A 212299 001 Sep 10, 2020 Sep NEWA >A> AB 50MG/25ML (2MG/ML) A 212299 002 Sep 10, 2020 Sep NEWA

DOXYCYCLINE HYCLATE CAPSULE;ORAL DOXYCYCLINE HYCLATE >D> AB ZHEJIANG YONGTAI EQ 50MG BASE A 212610 001 Mar 31, 2020 Sep DISC >A> @ EQ 50MG BASE A 212610 001 Mar 31, 2020 Sep DISC >D> AB EQ 100MG BASE A 212610 002 Mar 31, 2020 Sep DISC >A> @ EQ 100MG BASE A 212610 002 Mar 31, 2020 Sep DISC TABLET;ORAL DOXYCYCLINE HYCLATE >A> AB MYLAN EQ 75MG BASE A 209987 001 Oct 05, 2020 Sep NEWA >A> AB EQ 150MG BASE A 209987 002 Oct 05, 2020 Sep NEWA >D> AB OAKLOCK LLC EQ 100MG BASE A 210664 001 Mar 16, 2020 Sep DISC >A> @ EQ 100MG BASE A 210664 001 Mar 16, 2020 Sep DISC

DRONABINOL SOLUTION;ORAL SYNDROS >D> +! BENUVIA 5MG/ML N 205525 001 Mar 23, 2017 Sep CAHN >A> +! GUA ZHUANG 5MG/ML N 205525 001 Mar 23, 2017 Sep CAHN

DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS;ORAL DULOXETINE HYDROCHLORIDE >D> @ QINGDAO BAHEAL PHARM EQ 20MG BASE A 210599 001 Apr 17, 2019 Sep CMFD >A> AB EQ 20MG BASE A 210599 001 Apr 17, 2019 Sep CMFD >D> @ EQ 30MG BASE A 210599 002 Apr 17, 2019 Sep CMFD >A> AB EQ 30MG BASE A 210599 002 Apr 17, 2019 Sep CMFD >D> @ EQ 60MG BASE A 210599 003 Apr 17, 2019 Sep CMFD >A> AB EQ 60MG BASE A 210599 003 Apr 17, 2019 Sep CMFD

Page 10 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE >D> AB MACLEODS PHARMS LTD 200MG;300MG A 203442 001 May 15, 2020 Sep DISC >A> @ 200MG;300MG A 203442 001 May 15, 2020 Sep DISC

EPHEDRINE SULFATE SOLUTION;INTRAVENOUS EPHEDRINE SULFATE >A> AP DR REDDYS LABS LTD 50MG/ML (50MG/ML) A 212649 001 Oct 03, 2020 Sep NEWA

EPIRUBICIN HYDROCHLORIDE INJECTABLE;INJECTION EPIRUBICIN HYDROCHLORIDE >D> @ ZENNOVA 50MG/25ML (2MG/ML) A 090266 001 Apr 15, 2011 Sep CAHN >A> @ 50MG/25ML (2MG/ML) A 090266 001 Apr 15, 2011 Sep CAHN >D> @ 200MG/100ML (2MG/ML) A 090266 002 Apr 15, 2011 Sep CAHN >A> @ 200MG/100ML (2MG/ML) A 090266 002 Apr 15, 2011 Sep CAHN

EPTIFIBATIDE INJECTABLE;INJECTION >D> AP AMNEAL PHARMS 2MG/ML A 205581 001 Dec 08, 2016 Sep DISC >A> @ 2MG/ML A 205581 001 Dec 08, 2016 Sep DISC >D> AP 75MG/100ML A 205581 002 Dec 08, 2016 Sep DISC >A> @ 75MG/100ML A 205581 002 Dec 08, 2016 Sep DISC >D> AP HYBIO 2MG/ML A 207864 001 Mar 20, 2020 Sep DISC >A> @ 2MG/ML A 207864 001 Mar 20, 2020 Sep DISC >D> AP 75MG/100ML A 207864 002 Mar 20, 2020 Sep DISC >A> @ 75MG/100ML A 207864 002 Mar 20, 2020 Sep DISC

ERYTHROMYCIN LACTOBIONATE INJECTABLE;INJECTION ERYTHROMYCIN LACTOBIONATE >A> AP EXELA PHARMA EQ 500MG BASE/VIAL A 211086 001 Sep 17, 2020 Sep NEWA

ESCITALOPRAM TABLET;ORAL ESCITALOPRAM OXALATE >D> AB HIKMA PHARMS EQ 5MG BASE A 078766 001 Sep 11, 2012 Sep DISC >A> @ EQ 5MG BASE A 078766 001 Sep 11, 2012 Sep DISC >D> AB EQ 10MG BASE A 078766 002 Sep 11, 2012 Sep DISC >A> @ EQ 10MG BASE A 078766 002 Sep 11, 2012 Sep DISC >D> AB EQ 20MG BASE A 078766 003 Sep 11, 2012 Sep DISC >A> @ EQ 20MG BASE A 078766 003 Sep 11, 2012 Sep DISC

ESOMEPRAZOLE CAPSULE, DELAYED REL PELLETS;ORAL MAGNESIUM >A> AB CISEN EQ 20MG BASE A 213158 001 Sep 22, 2020 Sep NEWA >A> AB EQ 40MG BASE A 213158 002 Sep 22, 2020 Sep NEWA >A> AB CSPC OUYI EQ 20MG BASE A 212949 001 Oct 02, 2020 Sep NEWA >A> AB EQ 40MG BASE A 212949 002 Oct 02, 2020 Sep NEWA

ESOMEPRAZOLE STRONTIUM CAPSULE, DELAYED RELEASE;ORAL ESOMEPRAZOLE STRONTIUM >D> + @ BELCHER 24.65MG N 202342 001 Aug 06, 2013 Sep CAHN >A> + @ 24.65MG N 202342 001 Aug 06, 2013 Sep CAHN >D> + @ 49.3MG N 202342 002 Aug 06, 2013 Sep CAHN >A> + @ 49.3MG N 202342 002 Aug 06, 2013 Sep CAHN

ESTRADIOL FILM, EXTENDED RELEASE;TRANSDERMAL >A> AB3 AMNEAL 0.025MG/24HR A 211396 001 Sep 28, 2020 Sep NEWA >A> AB3 0.0375MG/24HR A 211396 002 Sep 28, 2020 Sep NEWA >A> AB3 0.05MG/24HR A 211396 003 Sep 28, 2020 Sep NEWA >A> AB3 0.075MG/24HR A 211396 004 Sep 28, 2020 Sep NEWA >A> AB3 0.1MG/24HR A 211396 005 Sep 28, 2020 Sep NEWA

Page 11 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ETHINYL ESTRADIOL; LEVONORGESTREL >D> TABLET, CHEWABLE;ORAL >D> TYBLUME >D> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Sep CDFR >A> TABLET;ORAL >A> TYBLUME >A> +! EXELTIS USA INC 0.02MG;0.1MG N 209405 001 Mar 30, 2020 Sep CDFR TABLET;ORAL-28 LEVONORGESTREL AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 0.02MG;0.1MG A 207065 001 Aug 17, 2020 Sep CAHN >A> AB NAARI PTE LTD 0.02MG;0.1MG A 207065 001 Aug 17, 2020 Sep CAHN

ETODOLAC CAPSULE;ORAL ETODOLAC >D> @ ECI PHARMS LLC 300MG A 074929 001 Jan 30, 1998 Sep CAHN >A> @ PHARMA LIFE 300MG A 074929 001 Jan 30, 1998 Sep CAHN TABLET;ORAL ETODOLAC >D> @ ECI PHARMS LLC 400MG A 074927 001 Oct 30, 1997 Sep CAHN >D> @ INVATECH 400MG A 074839 001 Jul 11, 1997 Sep CAHN >D> @ 400MG A 074846 001 Feb 28, 1997 Sep CAHN >A> @ PHARMA LIFE 400MG A 074927 001 Oct 30, 1997 Sep CAHN >A> @ PHARMGEN 400MG A 074839 001 Jul 11, 1997 Sep CAHN >A> @ 400MG A 074846 001 Feb 28, 1997 Sep CAHN

FAMCICLOVIR TABLET;ORAL FAMCICLOVIR >D> AB HIKMA 125MG A 090128 001 Mar 21, 2011 Sep DISC >A> @ 125MG A 090128 001 Mar 21, 2011 Sep DISC >D> AB 250MG A 090128 002 Mar 21, 2011 Sep DISC >A> @ 250MG A 090128 002 Mar 21, 2011 Sep DISC >D> AB 500MG A 090128 003 Mar 21, 2011 Sep DISC >A> @ 500MG A 090128 003 Mar 21, 2011 Sep DISC

FENTANYL FILM, EXTENDED RELEASE;TRANSDERMAL FENTANYL-100 >D> AB LAVIPHARM LABS 100MCG/HR A 077051 004 Aug 04, 2006 Sep DISC >A> @ 100MCG/HR A 077051 004 Aug 04, 2006 Sep DISC FENTANYL-25 >D> AB LAVIPHARM LABS 25MCG/HR A 077051 001 Aug 04, 2006 Sep DISC >A> @ 25MCG/HR A 077051 001 Aug 04, 2006 Sep DISC FENTANYL-50 >D> AB LAVIPHARM LABS 50MCG/HR A 077051 002 Aug 04, 2006 Sep DISC >A> @ 50MCG/HR A 077051 002 Aug 04, 2006 Sep DISC FENTANYL-75 >D> AB LAVIPHARM LABS 75MCG/HR A 077051 003 Aug 04, 2006 Sep DISC >A> @ 75MCG/HR A 077051 003 Aug 04, 2006 Sep DISC

>D> FERRIC MALTOL >D> CAPSULE;ORAL >D> ACCRUFER >D> +! SHIELD TX 30MG IRON N 212320 001 Jul 25, 2019 Sep DISC >A> + @ 30MG IRON N 212320 001 Jul 25, 2019 Sep DISC

FLECAINIDE ACETATE TABLET;ORAL FLECAINIDE ACETATE >A> AB BEXIMCO PHARMS USA 50MG A 210683 001 Sep 16, 2020 Sep NEWA >A> AB 100MG A 210683 002 Sep 16, 2020 Sep NEWA >A> AB 150MG A 210683 003 Sep 16, 2020 Sep NEWA

FLUDROCORTISONE ACETATE TABLET;ORAL FLUDROCORTISONE ACETATE >D> AB HIKMA PHARMS 0.1MG A 091302 001 Jul 22, 2011 Sep DISC >A> @ 0.1MG A 091302 001 Jul 22, 2011 Sep DISC

Page 12 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FLUOROURACIL INJECTABLE;INJECTION FLUOROURACIL >D> @ INGENUS PHARMS LLC 500MG/10ML (50MG/ML) A 209219 001 Dec 12, 2019 Sep CAHN >D> @ 500MG/10ML (50MG/ML) A 209271 001 Dec 11, 2019 Sep CAHN >D> @ 1GM/20ML (50MG/ML) A 209219 002 Dec 12, 2019 Sep CAHN >D> @ 2.5GM/50ML (50MG/ML) A 209271 002 Dec 11, 2019 Sep CAHN >A> @ NOVAST LABS 500MG/10ML (50MG/ML) A 209219 001 Dec 12, 2019 Sep CAHN >A> @ 500MG/10ML (50MG/ML) A 209271 001 Dec 11, 2019 Sep CAHN >A> @ 1GM/20ML (50MG/ML) A 209219 002 Dec 12, 2019 Sep CAHN >A> @ 2.5GM/50ML (50MG/ML) A 209271 002 Dec 11, 2019 Sep CAHN

FLURBIPROFEN TABLET;ORAL FLURBIPROFEN >D> MYLAN 50MG A 074358 001 Jun 20, 1994 Sep DISC >A> @ 50MG A 074358 001 Jun 20, 1994 Sep DISC >D> AB ! 100MG A 074358 002 Jun 20, 1994 Sep DISC >A> @ 100MG A 074358 002 Jun 20, 1994 Sep DISC >D> AB TEVA 100MG A 074431 001 May 31, 1995 Sep CHRS >A> AB ! 100MG A 074431 001 May 31, 1995 Sep CHRS >A> ! 100MG A 074431 001 May 31, 1995 Sep CTEC

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE POWDER;INHALATION TRELEGY ELLIPTA >A> +! GLAXOSMITHKLINE 0.2MG/INH;EQ 0.0625MG N 209482 002 Sep 09, 2020 Sep NEWA BASE/INH;EQ 0.025MG BASE/INH

FLUVOXAMINE MALEATE CAPSULE, EXTENDED RELEASE;ORAL FLUVOXAMINE MALEATE >A> AB BIONPHARMA INC 100MG A 212182 002 Sep 16, 2020 Sep NEWA TABLET;ORAL FLUVOXAMINE MALEATE >D> @ ECI PHARMS LLC 25MG A 075900 001 Feb 23, 2006 Sep CAHN >D> @ 50MG A 075900 002 Feb 23, 2006 Sep CAHN >D> @ 100MG A 075900 003 Feb 23, 2006 Sep CAHN >A> @ PHARMA LIFE 25MG A 075900 001 Feb 23, 2006 Sep CAHN >A> @ 50MG A 075900 002 Feb 23, 2006 Sep CAHN >A> @ 100MG A 075900 003 Feb 23, 2006 Sep CAHN

FOLIC ACID TABLET;ORAL FOLIC ACID >D> AA HIKMA 1MG A 080600 001 Mar 31, 1972 Sep DISC >A> @ HIKMA PHARMS 1MG A 080600 001 Mar 31, 1972 Sep DISC

FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL >A> FOSFOMYCIN TROMETHAMINE >A> AA XIROMED EQ 3GM BASE/PACKET A 212548 001 Oct 06, 2020 Sep NFTG MONUROL >D> +! ZAMBON SPA EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Sep CFTG >A> AA +! EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Sep CFTG

FOSPHENYTOIN SODIUM INJECTABLE;INJECTION FOSPHENYTOIN SODIUM >D> AP AMNEAL EQ 50MG PHENYTOIN NA/ML A 078476 001 Mar 18, 2008 Sep DISC >A> @ EQ 50MG PHENYTOIN NA/ML A 078476 001 Mar 18, 2008 Sep DISC

FUROSEMIDE INJECTABLE;INJECTION FUROSEMIDE >D> AP AMNEAL PHARMS CO 10MG/ML A 207552 001 Jul 20, 2016 Sep DISC >A> @ 10MG/ML A 207552 001 Jul 20, 2016 Sep DISC

Page 13 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GADOTERATE MEGLUMINE SOLUTION;INTRAVENOUS CLARISCAN >A> AP GE HEALTHCARE 37.69GM/100ML (376.9MG/ML) A 210016 004 Aug 04, 2020 Sep NFTG DOTAREM >D> +! GUERBET 37.69GM/100ML (376.9MG/ML) N 204781 001 Mar 20, 2013 Sep CFTG >A> AP +! 37.69GM/100ML (376.9MG/ML) N 204781 001 Mar 20, 2013 Sep CFTG

GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION GEMCITABINE HYDROCHLORIDE >D> @ INGENUS PHARMS LLC 200MG/5.26ML (38MG/ML) A 210383 001 Feb 14, 2019 Sep CAHN >D> @ 1GM/26.3ML (38MG/ML) A 210383 002 Feb 14, 2019 Sep CAHN >D> @ 2GM/52.6ML (38MG/ML) A 210383 003 Feb 14, 2019 Sep CAHN >A> @ NOVAST LABS 200MG/5.26ML (38MG/ML) A 210383 001 Feb 14, 2019 Sep CAHN >A> @ 1GM/26.3ML (38MG/ML) A 210383 002 Feb 14, 2019 Sep CAHN >A> @ 2GM/52.6ML (38MG/ML) A 210383 003 Feb 14, 2019 Sep CAHN

GEMFIBROZIL TABLET;ORAL GEMFIBROZIL >D> AB HIKMA PHARMS 600MG A 078599 001 Aug 16, 2010 Sep DISC >A> @ 600MG A 078599 001 Aug 16, 2010 Sep DISC

GLYBURIDE TABLET;ORAL GLYBURIDE >D> AB1 PHARMADAX INC 1.25MG A 203581 001 Apr 14, 2016 Sep CAHN >D> AB1 2.5MG A 203581 002 Apr 14, 2016 Sep CAHN >D> AB1 5MG A 203581 003 Apr 14, 2016 Sep CAHN >A> AB1 SWISS PHARM 1.25MG A 203581 001 Apr 14, 2016 Sep CAHN >A> AB1 2.5MG A 203581 002 Apr 14, 2016 Sep CAHN >A> AB1 5MG A 203581 003 Apr 14, 2016 Sep CAHN

GUANIDINE HYDROCHLORIDE TABLET;ORAL >D> GUANIDINE HYDROCHLORIDE >D> MERCK SHARP DOHME 125MG N 001546 001 Oct 02, 1939 Sep DISC >A> @ 125MG N 001546 001 Oct 02, 1939 Sep DISC

HALOBETASOL PROPIONATE OINTMENT;TOPICAL HALOBETASOL PROPIONATE >A> AB QUAGEN 0.05% A 213560 001 Oct 06, 2020 Sep NEWA

HEPARIN SODIUM INJECTABLE;INJECTION SODIUM PRESERVATIVE FREE >D> ! HOSPIRA 10,000 UNITS/ML A 089522 001 May 04, 1987 Sep DISC >A> @ 10,000 UNITS/ML A 089522 001 May 04, 1987 Sep DISC

HYDRALAZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDRALAZINE HYDROCHLORIDE >A> AP I3 PHARMS 20MG/ML A 203110 001 Jun 29, 2015 Sep CAHN >D> AP XGEN PHARMS 20MG/ML A 203110 001 Jun 29, 2015 Sep CAHN

HYDROCHLOROTHIAZIDE TABLET;ORAL HYDROCHLOROTHIAZIDE >D> AB HIKMA INTL PHARMS 50MG A 084878 001 Jan 31, 1977 Sep DISC >A> @ 50MG A 084878 001 Jan 31, 1977 Sep DISC

HYDROCHLOROTHIAZIDE; LISINOPRIL TABLET;ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE >D> AB HIKMA INTL PHARMS 12.5MG;10MG A 076265 001 Jul 08, 2002 Sep DISC >A> @ 12.5MG;10MG A 076265 001 Jul 08, 2002 Sep DISC >D> AB 12.5MG;20MG A 076265 002 Jul 08, 2002 Sep DISC >A> @ 12.5MG;20MG A 076265 002 Jul 08, 2002 Sep DISC >D> AB 25MG;20MG A 076265 003 Jul 08, 2002 Sep DISC

Page 14 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCHLOROTHIAZIDE; LISINOPRIL TABLET;ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE >A> @ 25MG;20MG A 076265 003 Jul 08, 2002 Sep DISC

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE >D> AB HIKMA 12.5MG;50MG A 077732 002 Oct 06, 2010 Sep DISC >A> @ 12.5MG;50MG A 077732 002 Oct 06, 2010 Sep DISC >D> AB 12.5MG;100MG A 077732 001 Apr 06, 2010 Sep DISC >A> @ 12.5MG;100MG A 077732 001 Apr 06, 2010 Sep DISC >D> AB 25MG;100MG A 077732 003 Oct 06, 2010 Sep DISC >A> @ 25MG;100MG A 077732 003 Oct 06, 2010 Sep DISC

HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE TABLET;ORAL LOPRESSOR HCT >D> AB +! US PHARMS HOLDINGS I 25MG;100MG N 018303 002 Dec 31, 1984 Sep DISC >A> + @ 25MG;100MG N 018303 002 Dec 31, 1984 Sep DISC METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE >D> AB ALEMBIC PHARMS LTD 25MG;100MG A 202870 002 Nov 06, 2013 Sep CHRS >A> AB ! 25MG;100MG A 202870 002 Nov 06, 2013 Sep CHRS

HYDROCORTISONE GRANULE;ORAL >A> ALKINDI SPRINKLE >A> + ETON 0.5MG N 213876 001 Sep 29, 2020 Sep NEWA >A> + 1MG N 213876 002 Sep 29, 2020 Sep NEWA >A> + 2MG N 213876 003 Sep 29, 2020 Sep NEWA >A> +! 5MG N 213876 004 Sep 29, 2020 Sep NEWA TABLET;ORAL HYDROCORTISONE >D> AB HIKMA INTL PHARMS 5MG A 083365 002 Feb 23, 2015 Sep DISC >A> @ 5MG A 083365 002 Feb 23, 2015 Sep DISC >D> AB 10MG A 083365 003 Feb 23, 2015 Sep DISC >A> @ 10MG A 083365 003 Feb 23, 2015 Sep DISC >D> AB 20MG A 083365 001 Jun 18, 1973 Sep DISC >A> @ 20MG A 083365 001 Jun 18, 1973 Sep DISC

HYDROMORPHONE HYDROCHLORIDE INJECTABLE;INJECTION DILAUDID >D> AP +! FRESENIUS KABI USA 1MG/ML N 019034 003 Apr 30, 2009 Sep CTEC >A> +! 1MG/ML N 019034 003 Apr 30, 2009 Sep CTEC HYDROMORPHONE HYDROCHLORIDE >D> AP HOSPIRA INC 1MG/ML N 200403 001 Dec 01, 2011 Sep DISC >A> @ 1MG/ML N 200403 001 Dec 01, 2011 Sep DISC >D> AP 2MG/ML N 200403 002 Dec 01, 2011 Sep DISC >A> @ 2MG/ML N 200403 002 Dec 01, 2011 Sep DISC TABLET, EXTENDED RELEASE;ORAL HYDROMORPHONE HYDROCHLORIDE >A> AB ASCENT PHARMS INC 8MG A 212133 001 Sep 23, 2020 Sep NEWA >A> AB 12MG A 212133 002 Sep 23, 2020 Sep NEWA >A> AB 16MG A 212133 003 Sep 23, 2020 Sep NEWA >A> AB 32MG A 212133 004 Sep 23, 2020 Sep NEWA

HYDROXYCHLOROQUINE SULFATE TABLET;ORAL HYDROXYCHLOROQUINE SULFATE >D> AB APPCO 200MG A 210441 001 May 01, 2018 Sep CAHN >A> AB DR REDDYS 200MG A 210441 001 May 01, 2018 Sep CAHN >D> AB HIKMA 200MG A 040760 001 Aug 15, 2007 Sep DISC >A> @ HIKMA PHARMS 200MG A 040760 001 Aug 15, 2007 Sep DISC

Page 15 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROXYZINE HYDROCHLORIDE TABLET;ORAL HYDROXYZINE HYDROCHLORIDE >A> AB DISCOVERY THERAP 10MG A 040804 001 Jun 30, 2008 Sep CAHN >A> AB 25MG A 040804 002 Jun 30, 2008 Sep CAHN >A> AB 50MG A 040804 003 Jun 30, 2008 Sep CAHN >D> AB ECI PHARMS LLC 10MG A 040804 001 Jun 30, 2008 Sep CAHN >D> AB 25MG A 040804 002 Jun 30, 2008 Sep CAHN >D> AB 50MG A 040804 003 Jun 30, 2008 Sep CAHN >A> AB NUVO PHARMS INC 10MG A 207121 002 Mar 29, 2017 Sep CMS1 >A> AB 50MG A 207121 003 Mar 29, 2017 Sep CMS1

IBANDRONATE SODIUM INJECTABLE;INTRAVENOUS BONIVA >D> AP +! ROCHE EQ 3MG BASE/3ML N 021858 001 Jan 06, 2006 Sep DISC >A> + @ EQ 3MG BASE/3ML N 021858 001 Jan 06, 2006 Sep DISC IBANDRONATE SODIUM >D> AP APOTEX EQ 3MG BASE/3ML A 204222 001 Oct 16, 2015 Sep CHRS >A> AP ! EQ 3MG BASE/3ML A 204222 001 Oct 16, 2015 Sep CHRS

ICATIBANT ACETATE INJECTABLE;SUBCUTANEOUS ICATIBANT ACETATE >A> AP DR REDDYS EQ 30MG BASE/3ML (EQ 10MG A 213054 001 Oct 05, 2020 Sep NEWA BASE/ML)

ICOSAPENT ETHYL CAPSULE;ORAL >A> ICOSAPENT ETHYL >A> AB TEVA PHARMS USA 500MG A 209525 001 Sep 11, 2020 Sep NFTG >A> AB 1GM A 209525 002 Sep 11, 2020 Sep NEWA VASCEPA >D> + AMARIN PHARMS 500MG N 202057 002 Feb 16, 2017 Sep CFTG >A> AB + 500MG N 202057 002 Feb 16, 2017 Sep CFTG

IRINOTECAN HYDROCHLORIDE INJECTABLE;INJECTION IRINOTECAN HYDROCHLORIDE >D> AP INGENUS PHARMS LLC 40MG/2ML (20MG/ML) A 206935 001 May 26, 2017 Sep CAHN >D> AP 100MG/5ML (20MG/ML) A 206935 002 May 26, 2017 Sep CAHN >A> AP NOVAST LABS 40MG/2ML (20MG/ML) A 206935 001 May 26, 2017 Sep CAHN >A> AP 100MG/5ML (20MG/ML) A 206935 002 May 26, 2017 Sep CAHN >A> AP SHILPA MEDICARE LTD 300MG/15ML (20MG/ML) A 208718 003 Aug 16, 2019 Sep NEWA >D> AP ZENNOVA 40MG/2ML (20MG/ML) A 090393 002 May 13, 2011 Sep CAHN >A> AP 40MG/2ML (20MG/ML) A 090393 002 May 13, 2011 Sep CAHN >D> AP 100MG/5ML (20MG/ML) A 090393 003 May 13, 2011 Sep CAHN >A> AP 100MG/5ML (20MG/ML) A 090393 003 May 13, 2011 Sep CAHN

ISOSORBIDE DINITRATE TABLET;ORAL ISOSORBIDE DINITRATE >D> AB HIKMA INTL PHARMS 30MG A 040591 001 Jan 10, 2007 Sep DISC >A> @ 30MG A 040591 001 Jan 10, 2007 Sep DISC

ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE;ORAL >D> AB VINTAGE PHARMS 30MG A 090598 001 Aug 11, 2010 Sep DISC >A> @ 30MG A 090598 001 Aug 11, 2010 Sep DISC >D> AB 60MG A 090598 002 Aug 11, 2010 Sep DISC >A> @ 60MG A 090598 002 Aug 11, 2010 Sep DISC >D> AB 120MG A 090598 003 Aug 11, 2010 Sep DISC >A> @ 120MG A 090598 003 Aug 11, 2010 Sep DISC TABLET;ORAL ISOSORBIDE MONONITRATE >D> AB HIKMA 20MG A 075361 001 Oct 05, 2000 Sep DISC >A> @ HIKMA PHARMS 20MG A 075361 001 Oct 05, 2000 Sep DISC

Page 16 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

KETOROLAC TROMETHAMINE INJECTABLE;INJECTION KETOROLAC TROMETHAMINE >D> AP AMPHASTAR PHARM 15MG/ML A 076209 001 Jul 21, 2004 Sep DISC >A> @ 15MG/ML A 076209 001 Jul 21, 2004 Sep DISC >D> AP 30MG/ML A 076209 002 Jul 21, 2004 Sep DISC >A> @ 30MG/ML A 076209 002 Jul 21, 2004 Sep DISC >D> AP HOSPIRA 15MG/ML A 074993 001 Jan 27, 1999 Sep DISC >A> @ 15MG/ML A 074993 001 Jan 27, 1999 Sep DISC >D> AP 30MG/ML A 074993 002 Jan 27, 1999 Sep DISC >A> @ 30MG/ML A 074993 002 Jan 27, 1999 Sep DISC

LABETALOL HYDROCHLORIDE TABLET;ORAL LABETALOL HYDROCHLORIDE >D> AB ATHEM 100MG A 207863 001 Feb 04, 2019 Sep CAHN >D> AB 200MG A 207863 002 Feb 04, 2019 Sep CAHN >D> AB 300MG A 207863 003 Feb 04, 2019 Sep CAHN >A> AB EPIC PHARMA LLC 100MG A 212990 001 Sep 30, 2020 Sep NEWA >A> AB 200MG A 212990 002 Sep 30, 2020 Sep NEWA >A> AB 300MG A 212990 003 Sep 30, 2020 Sep NEWA >A> AB EYWA 100MG A 207863 001 Feb 04, 2019 Sep CAHN >A> AB 200MG A 207863 002 Feb 04, 2019 Sep CAHN >A> AB 300MG A 207863 003 Feb 04, 2019 Sep CAHN

LACTULOSE SOLUTION;ORAL LACTULOSE >A> AA CHARTWELL RX 10GM/15ML A 209517 001 Nov 23, 2018 Sep CAHN >D> AA HIKMA 10GM/15ML A 073591 001 May 29, 1992 Sep DISC >A> @ 10GM/15ML A 073591 001 May 29, 1992 Sep DISC >D> AA LIFEPHARMA 10GM/15ML A 209517 001 Nov 23, 2018 Sep CAHN

LAMIVUDINE TABLET;ORAL LAMIVUDINE >A> AB BIOPHARM 150MG A 203586 001 Nov 21, 2016 Sep CAHN >D> AB ECI PHARMS LLC 150MG A 203586 001 Nov 21, 2016 Sep CAHN >A> AB PHARMA LIFE 150MG A 203586 001 Nov 21, 2016 Sep CAHN

LAPATINIB DITOSYLATE TABLET;ORAL >A> LAPATINIB DITOSYLATE >A> AB NATCO PHARMA LTD EQ 250MG BASE A 203007 001 Sep 29, 2020 Sep NFTG TYKERB >D> +! NOVARTIS EQ 250MG BASE N 022059 001 Mar 13, 2007 Sep CFTG >A> AB +! EQ 250MG BASE N 022059 001 Mar 13, 2007 Sep CFTG

LETROZOLE TABLET;ORAL LETROZOLE >D> AB HIKMA 2.5MG A 090838 001 Jun 03, 2011 Sep DISC >A> @ 2.5MG A 090838 001 Jun 03, 2011 Sep DISC >D> AB HIKMA PHARMS 2.5MG A 203796 001 Jun 03, 2016 Sep DISC >A> @ 2.5MG A 203796 001 Jun 03, 2016 Sep DISC

LEUCOVORIN TABLET;ORAL LEUCOVORIN CALCIUM >A> AB NOVAST LABS EQ 5MG BASE A 211132 001 Jul 30, 2020 Sep CAHN >A> AB EQ 10MG BASE A 211132 002 Jul 30, 2020 Sep CAHN >A> AB EQ 15MG BASE A 211132 003 Jul 30, 2020 Sep CAHN >A> AB EQ 25MG BASE A 211132 004 Jul 30, 2020 Sep CAHN >D> AB RICONPHARMA LLC EQ 5MG BASE A 211132 001 Jul 30, 2020 Sep CAHN >D> AB EQ 10MG BASE A 211132 002 Jul 30, 2020 Sep CAHN >D> AB EQ 15MG BASE A 211132 003 Jul 30, 2020 Sep CAHN >D> AB EQ 25MG BASE A 211132 004 Jul 30, 2020 Sep CAHN

Page 17 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LEVETIRACETAM TABLET, EXTENDED RELEASE;ORAL LEVETIRACETAM >D> AB DEXCEL PHARMA 500MG A 202167 001 Sep 04, 2015 Sep CAHN >D> AB 750MG A 202167 002 Sep 04, 2015 Sep CAHN >D> AB ECI PHARMS LLC 500MG A 204754 001 Aug 26, 2016 Sep CAHN >D> AB 750MG A 204754 002 Aug 26, 2016 Sep CAHN >A> AB FLORIDA 500MG A 202167 001 Sep 04, 2015 Sep CAHN >A> AB 750MG A 202167 002 Sep 04, 2015 Sep CAHN >A> AB PHARMA LIFE 500MG A 204754 001 Aug 26, 2016 Sep CAHN >A> AB 750MG A 204754 002 Aug 26, 2016 Sep CAHN

LEVOLEUCOVORIN CALCIUM SOLUTION;INTRAVENOUS LEVOLEUCOVORIN CALCIUM >D> AP ! INGENUS PHARMS LLC EQ 175MG BASE/17.5ML (EQ 10MG A 210623 001 May 03, 2018 Sep CAHN BASE/ML) >D> AP ! EQ 250MG BASE/25ML (EQ 10MG A 210623 002 May 03, 2018 Sep CAHN BASE/ML) >A> AP ! NOVAST LABS EQ 175MG BASE/17.5ML (EQ 10MG A 210623 001 May 03, 2018 Sep CAHN BASE/ML) >A> AP ! EQ 250MG BASE/25ML (EQ 10MG A 210623 002 May 03, 2018 Sep CAHN BASE/ML)

LIDOCAINE; PRILOCAINE CREAM;TOPICAL LIDOCAINE AND PRILOCAINE >A> AB RHODES PHARMS 2.5%;2.5% A 213253 001 Sep 21, 2020 Sep NEWA

LISINOPRIL TABLET;ORAL LISINOPRIL >D> @ INVATECH 2.5MG A 075999 001 Jul 01, 2002 Sep CAHN >D> @ 5MG A 075999 002 Jul 01, 2002 Sep CAHN >D> @ 10MG A 075999 003 Jul 01, 2002 Sep CAHN >D> @ 20MG A 075999 004 Jul 01, 2002 Sep CAHN >D> @ 30MG A 075999 005 Jul 01, 2002 Sep CAHN >D> @ 40MG A 075999 006 Jul 01, 2002 Sep CAHN >A> @ PHARMGEN 2.5MG A 075999 001 Jul 01, 2002 Sep CAHN >A> @ 5MG A 075999 002 Jul 01, 2002 Sep CAHN >A> @ 10MG A 075999 003 Jul 01, 2002 Sep CAHN >A> @ 20MG A 075999 004 Jul 01, 2002 Sep CAHN >A> @ 30MG A 075999 005 Jul 01, 2002 Sep CAHN >A> @ 40MG A 075999 006 Jul 01, 2002 Sep CAHN >A> AB YILING 2.5MG A 212041 001 Sep 15, 2020 Sep NEWA >A> AB 5MG A 212041 002 Sep 15, 2020 Sep NEWA >A> AB 10MG A 212041 003 Sep 15, 2020 Sep NEWA

>D> LOMITAPIDE MESYLATE >D> CAPSULE;ORAL >D> JUXTAPID >D> + AMRYT EQ 40MG BASE N 203858 005 Apr 23, 2015 Sep DISC >A> + @ EQ 40MG BASE N 203858 005 Apr 23, 2015 Sep DISC >D> +! EQ 60MG BASE N 203858 006 Apr 23, 2015 Sep DISC >A> + @ EQ 60MG BASE N 203858 006 Apr 23, 2015 Sep DISC

LORAZEPAM INJECTABLE;INJECTION LORAZEPAM >D> AP HOSPIRA 2MG/ML A 074243 001 Apr 12, 1994 Sep DISC >A> @ 2MG/ML A 074243 001 Apr 12, 1994 Sep DISC

MEFENAMIC ACID CAPSULE;ORAL MEFENAMIC ACID >A> AB STRIDES PHARMA 250MG A 209209 001 Sep 18, 2020 Sep NEWA

Page 18 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MEGESTROL ACETATE TABLET;ORAL MEGESTROL ACETATE >D> AB HIKMA 20MG A 074458 001 Sep 29, 1995 Sep DISC >A> @ 20MG A 074458 001 Sep 29, 1995 Sep DISC >D> AB 40MG A 074458 002 Sep 29, 1995 Sep DISC >A> @ 40MG A 074458 002 Sep 29, 1995 Sep DISC

MEMANTINE HYDROCHLORIDE SOLUTION;ORAL MEMANTINE HYDROCHLORIDE >D> AA MEDLEY PHARMS 2MG/ML A 210319 001 Aug 31, 2020 Sep CAHN >A> AA SAPTALIS PHARMS 2MG/ML A 210319 001 Aug 31, 2020 Sep CAHN

MESALAMINE SUPPOSITORY;RECTAL MESALAMINE >A> AB APTAPHARMA INC 1GM A 207448 001 Apr 19, 2019 Sep CAHN >D> AB PHARM SOURCING 1GM A 207448 001 Apr 19, 2019 Sep CAHN

METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL FORTAMET >D> + @ ANDRX LABS LLC 1GM N 021574 002 Apr 27, 2004 Sep CMFD >A> AB2 + 1GM N 021574 002 Apr 27, 2004 Sep CMFD HYDROCHLORIDE >D> @ MACLEODS PHARMS LTD 500MG A 206955 001 Dec 07, 2016 Sep CMFD >A> AB1 500MG A 206955 001 Dec 07, 2016 Sep CMFD >D> @ 750MG A 206955 002 Dec 07, 2016 Sep CMFD >A> AB 750MG A 206955 002 Dec 07, 2016 Sep CMFD

METHADONE HYDROCHLORIDE TABLET;ORAL METHADONE HYDROCHLORIDE >A> AA THEPHARMANETWORK LLC 5MG A 090635 002 Sep 22, 2020 Sep NEWA

METHAZOLAMIDE TABLET;ORAL METHAZOLAMIDE >A> @ ATHEM 25MG A 040102 001 Aug 28, 1996 Sep CAHN >A> @ 50MG A 040102 002 Aug 28, 1996 Sep CAHN >D> @ INVATECH 25MG A 040102 001 Aug 28, 1996 Sep CAHN >D> @ 50MG A 040102 002 Aug 28, 1996 Sep CAHN

METHIMAZOLE TABLET;ORAL METHIMAZOLE >A> AB DISCOVERY THERAP 5MG A 040547 001 Feb 18, 2005 Sep CAHN >A> AB 10MG A 040547 002 Feb 18, 2005 Sep CAHN >A> @ 15MG A 040619 003 Jul 12, 2005 Sep CAHN >A> @ 20MG A 040547 004 Feb 18, 2005 Sep CAHN >D> AB ECI PHARMS LLC 5MG A 040547 001 Feb 18, 2005 Sep CAHN >D> AB 10MG A 040547 002 Feb 18, 2005 Sep CAHN >D> @ 15MG A 040619 003 Jul 12, 2005 Sep CAHN >D> @ 20MG A 040547 004 Feb 18, 2005 Sep CAHN

METHOTREXATE >D> SOLUTION;INTRAVENOUS >D> >D> +! ACCORD HLTHCARE 5GM/50ML (100MG/ML) N 214121 001 Aug 24, 2020 Sep DISC >A> + @ 5GM/50ML (100MG/ML) N 214121 001 Aug 24, 2020 Sep DISC

METHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL ADHANSIA XR >D> + PURDUE PHARMA LP 85MG N 212038 006 Feb 27, 2019 Sep CHRS >A> +! 85MG N 212038 006 Feb 27, 2019 Sep CHRS JORNAY PM >D> + IRONSHORE PHARMS 100MG N 209311 005 Aug 08, 2018 Sep CHRS >A> +! 100MG N 209311 005 Aug 08, 2018 Sep CHRS

Page 19 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPHENIDATE HYDROCHLORIDE SOLUTION;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AA EYWA 5MG/5ML A 210139 001 Oct 03, 2018 Sep CAHN >A> AA 10MG/5ML A 210139 002 Oct 03, 2018 Sep CAHN >D> AA NOVELGENIX THERAPS 5MG/5ML A 210139 001 Oct 03, 2018 Sep CAHN >D> AA 10MG/5ML A 210139 002 Oct 03, 2018 Sep CAHN TABLET, EXTENDED RELEASE;ORAL METHYLPHENIDATE HYDROCHLORIDE >A> AB ALKEM LABS LTD 20MG A 212288 001 Oct 06, 2020 Sep NEWA

METHYLPREDNISOLONE TABLET;ORAL METHYLPREDNISOLONE >D> @ NOVAST LABS 4MG A 210985 001 Jan 09, 2019 Sep CMFD >A> AB 4MG A 210985 001 Jan 09, 2019 Sep CMFD

METHYLTESTOSTERONE CAPSULE;ORAL TESTRED >A> AB ! BAUSCH 10MG A 083976 001 Dec 03, 1973 Sep CAHN >D> AB ! VALEANT PHARM INTL 10MG A 083976 001 Dec 03, 1973 Sep CAHN

METRONIDAZOLE GEL;VAGINAL VANDAZOLE >D> BX TEVA PHARMS 0.75% N 021806 001 May 20, 2005 Sep CHRS >A> BX ! 0.75% N 021806 001 May 20, 2005 Sep CHRS

MICONAZOLE >D> TABLET;BUCCAL >D> ORAVIG >D> +! FORTOVIA 50MG N 022404 001 Apr 16, 2010 Sep DISC >A> + @ 50MG N 022404 001 Apr 16, 2010 Sep DISC

MIDAZOLAM HYDROCHLORIDE INJECTABLE;INJECTION MIDAZOLAM HYDROCHLORIDE >D> AP HOSPIRA EQ 1MG BASE/ML A 075856 001 Jun 13, 2002 Sep DISC >A> @ EQ 1MG BASE/ML A 075856 001 Jun 13, 2002 Sep DISC

MIDODRINE HYDROCHLORIDE TABLET;ORAL MIDODRINE HYDROCHLORIDE >A> AB CEROVENE INC 2.5MG A 207849 001 Oct 01, 2020 Sep NEWA >A> AB 5MG A 207849 002 Oct 01, 2020 Sep NEWA >A> AB 10MG A 207849 003 Oct 01, 2020 Sep NEWA

MIGLUSTAT CAPSULE;ORAL MIGLUSTAT >D> AB AMERIGEN PHARMS LTD 100MG A 208342 001 Apr 17, 2018 Sep CAHN >A> AB ANI PHARMS INC 100MG A 208342 001 Apr 17, 2018 Sep CAHN

MILNACIPRAN HYDROCHLORIDE TABLET;ORAL MILNACIPRAN HYDROCHLORIDE >A> @ ANDA REPOSITORY 12.5MG A 205071 001 Jan 27, 2016 Sep CAHN >A> @ 25MG A 205071 002 Jan 27, 2016 Sep CAHN >A> @ 50MG A 205071 003 Jan 27, 2016 Sep CAHN >A> @ 100MG A 205071 004 Jan 27, 2016 Sep CAHN >D> @ USPHARMA WINDLAS 12.5MG A 205071 001 Jan 27, 2016 Sep CAHN >D> @ 25MG A 205071 002 Jan 27, 2016 Sep CAHN >D> @ 50MG A 205071 003 Jan 27, 2016 Sep CAHN >D> @ 100MG A 205071 004 Jan 27, 2016 Sep CAHN

Page 20 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MISOPROSTOL TABLET;ORAL MISOPROSTOL >A> @ ACQ PHARMA 0.1MG A 210201 001 Jul 02, 2019 Sep CAHN >A> @ 0.2MG A 210201 002 Jul 02, 2019 Sep CAHN >D> @ ZYDUS PHARMS 0.1MG A 210201 001 Jul 02, 2019 Sep CAHN >D> @ 0.2MG A 210201 002 Jul 02, 2019 Sep CAHN

MOMETASONE FUROATE CREAM;TOPICAL MOMETASONE FUROATE >D> AB FOUGERA PHARMS 0.1% A 076171 001 Apr 08, 2005 Sep DISC >A> @ 0.1% A 076171 001 Apr 08, 2005 Sep DISC

MONTELUKAST SODIUM TABLET, CHEWABLE;ORAL MONTELUKAST SODIUM >A> AB ADAPTIS EQ 4MG BASE A 209011 001 Apr 18, 2017 Sep CAHN >A> AB EQ 5MG BASE A 209011 002 Apr 18, 2017 Sep CAHN >D> AB GRAVITI PHARMS EQ 4MG BASE A 209011 001 Apr 18, 2017 Sep CAHN >D> AB EQ 5MG BASE A 209011 002 Apr 18, 2017 Sep CAHN TABLET;ORAL MONTELUKAST SODIUM >A> AB ADAPTIS EQ 10MG BASE A 209012 001 Apr 24, 2017 Sep CAHN >D> AB GRAVITI PHARMS EQ 10MG BASE A 209012 001 Apr 24, 2017 Sep CAHN

MORPHINE SULFATE INJECTABLE;INJECTION SULFATE >D> AP HIKMA 4MG/ML A 205758 001 May 21, 2015 Sep CHRS >A> AP ! 4MG/ML A 205758 001 May 21, 2015 Sep CHRS >A> ! 4MG/ML A 205758 001 May 21, 2015 Sep CTEC >D> AP 8MG/ML A 205758 002 May 21, 2015 Sep CHRS >A> ! 8MG/ML A 205758 002 May 21, 2015 Sep CTEC >A> AP ! 8MG/ML A 205758 002 May 21, 2015 Sep CHRS >D> +! HOSPIRA INC 2MG/ML N 202515 001 Nov 14, 2011 Sep DISC >A> + @ 2MG/ML N 202515 001 Nov 14, 2011 Sep DISC >D> AP +! 4MG/ML N 202515 002 Nov 14, 2011 Sep DISC >A> + @ 4MG/ML N 202515 002 Nov 14, 2011 Sep DISC >D> AP +! 8MG/ML N 202515 003 Nov 14, 2011 Sep DISC >A> + @ 8MG/ML N 202515 003 Nov 14, 2011 Sep DISC >D> AP +! 10MG/ML N 202515 004 Nov 14, 2011 Sep DISC >A> + @ 10MG/ML N 202515 004 Nov 14, 2011 Sep DISC SOLUTION;INTRAMUSCULAR >D> MORPHINE SULFATE (AUTOINJECTOR) >D> +! MERIDIAN MEDCL TECHN 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Sep DISC >A> + @ 10MG/0.7ML (10MG/0.7ML) N 019999 001 Jul 12, 1990 Sep DISC

NABUMETONE TABLET;ORAL NABUMETONE >D> AB IMPAX LABS INC 500MG A 075189 001 May 26, 2000 Sep DISC >A> @ 500MG A 075189 001 May 26, 2000 Sep DISC >D> AB 750MG A 075189 002 Sep 24, 2001 Sep DISC >A> @ 750MG A 075189 002 Sep 24, 2001 Sep DISC

NAFTIFINE HYDROCHLORIDE CREAM;TOPICAL NAFTIFINE HYDROCHLORIDE >A> AB GENZUM 2.0% A 210038 001 Sep 22, 2020 Sep NEWA

NALOXONE HYDROCHLORIDE SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS EVZIO (AUTOINJECTOR) >D> +! KALEO INC 2MG/0.4ML (2MG/0.4ML) N 209862 001 Oct 19, 2016 Sep DISC >A> + @ 2MG/0.4ML (2MG/0.4ML) N 209862 001 Oct 19, 2016 Sep DISC

Page 21 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NAPROXEN TABLET, DELAYED RELEASE;ORAL NAPROXEN >A> AB NUVO PHARMS INC 375MG A 091432 001 Sep 19, 2011 Sep CAHN >A> AB 500MG A 091432 002 Sep 19, 2011 Sep CAHN >D> AB SUNRISE PHARM INC 375MG A 091432 001 Sep 19, 2011 Sep CAHN >D> AB 500MG A 091432 002 Sep 19, 2011 Sep CAHN TABLET;ORAL NAPROXEN >D> @ FOSUN PHARMA 250MG A 074140 001 Dec 21, 1993 Sep CAHN >D> @ 375MG A 074140 002 Dec 21, 1993 Sep CAHN >D> @ 500MG A 074140 003 Dec 21, 1993 Sep CAHN >A> @ GRANULES 250MG A 074140 001 Dec 21, 1993 Sep CAHN >A> @ 375MG A 074140 002 Dec 21, 1993 Sep CAHN >A> @ 500MG A 074140 003 Dec 21, 1993 Sep CAHN

NATEGLINIDE TABLET;ORAL NATEGLINIDE >A> AB INDICUS PHARMA 60MG A 205544 001 Jun 18, 2018 Sep CAHN >A> AB 120MG A 205544 002 Jun 18, 2018 Sep CAHN >D> AB WILSHIRE PHARMS INC 60MG A 205544 001 Jun 18, 2018 Sep CAHN >D> AB 120MG A 205544 002 Jun 18, 2018 Sep CAHN

NEBIVOLOL HYDROCHLORIDE TABLET;ORAL NEBIVOLOL HYDROCHLORIDE >D> @ AMERIGEN PHARMS LTD EQ 2.5MG BASE A 203659 001 Apr 16, 2015 Sep CAHN >D> @ EQ 5MG BASE A 203659 002 Apr 16, 2015 Sep CAHN >D> @ EQ 10MG BASE A 203659 003 Apr 16, 2015 Sep CAHN >D> @ EQ 20MG BASE A 203659 004 Apr 16, 2015 Sep CAHN >A> @ ANI PHARMS INC EQ 2.5MG BASE A 203659 001 Apr 16, 2015 Sep CAHN >A> @ EQ 5MG BASE A 203659 002 Apr 16, 2015 Sep CAHN >A> @ EQ 10MG BASE A 203659 003 Apr 16, 2015 Sep CAHN >A> @ EQ 20MG BASE A 203659 004 Apr 16, 2015 Sep CAHN

NITROFURANTOIN, MACROCRYSTALLINE CAPSULE;ORAL NITROFURANTOIN >D> @ INVATECH 25MG A 074336 001 Jan 25, 1995 Sep CAHN >D> @ 50MG A 074336 002 Jan 25, 1995 Sep CAHN >D> @ 100MG A 074336 003 Jan 25, 1995 Sep CAHN >A> @ PHARMGEN 25MG A 074336 001 Jan 25, 1995 Sep CAHN >A> @ 50MG A 074336 002 Jan 25, 1995 Sep CAHN >A> @ 100MG A 074336 003 Jan 25, 1995 Sep CAHN

OLANZAPINE TABLET;ORAL OLANZAPINE >D> AB HIKMA 2.5MG A 204866 001 Jun 16, 2017 Sep DISC >A> @ 2.5MG A 204866 001 Jun 16, 2017 Sep DISC >D> AB 5MG A 204866 002 Jun 16, 2017 Sep DISC >A> @ 5MG A 204866 002 Jun 16, 2017 Sep DISC >D> AB 7.5MG A 204866 003 Jun 16, 2017 Sep DISC >A> @ 7.5MG A 204866 003 Jun 16, 2017 Sep DISC >D> AB 10MG A 204866 004 Jun 16, 2017 Sep DISC >A> @ 10MG A 204866 004 Jun 16, 2017 Sep DISC >D> AB 15MG A 204866 005 Jun 16, 2017 Sep DISC >A> @ 15MG A 204866 005 Jun 16, 2017 Sep DISC >D> AB 20MG A 204866 006 Jun 16, 2017 Sep DISC >A> @ 20MG A 204866 006 Jun 16, 2017 Sep DISC

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE >D> AT SOMERSET THERAPS LLC EQ 0.1% BASE A 206306 001 Dec 07, 2015 Sep DISC >A> @ EQ 0.1% BASE A 206306 001 Dec 07, 2015 Sep DISC

Page 22 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ONDANSETRON >D> FILM;ORAL >D> ZUPLENZ >D> + FORTOVIA 4MG N 022524 001 Jul 02, 2010 Sep DISC >A> + @ 4MG N 022524 001 Jul 02, 2010 Sep DISC >D> +! 8MG N 022524 002 Jul 02, 2010 Sep DISC >A> + @ 8MG N 022524 002 Jul 02, 2010 Sep DISC

ONDANSETRON HYDROCHLORIDE INJECTABLE;INJECTION ONDANSETRON HYDROCHLORIDE >D> AP HOSPIRA EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Sep DISC >A> @ EQ 2MG BASE/ML A 077840 001 Jan 19, 2007 Sep DISC

OXYBUTYNIN CHLORIDE TABLET;ORAL OXYBUTYNIN CHLORIDE >D> AB ATHEM 5MG A 211062 001 Feb 06, 2019 Sep CAHN >A> AB EYWA 5MG A 211062 001 Feb 06, 2019 Sep CAHN

OXYMORPHONE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL OXYMORPHONE HYDROCHLORIDE >D> AB HIKMA 5MG A 200822 002 Jul 15, 2013 Sep DISC >A> @ 5MG A 200822 002 Jul 15, 2013 Sep DISC >D> AB 7.5MG A 200822 003 Jul 15, 2013 Sep DISC >A> @ 7.5MG A 200822 003 Jul 15, 2013 Sep DISC >D> AB 10MG A 200822 004 Jul 15, 2013 Sep DISC >A> @ 10MG A 200822 004 Jul 15, 2013 Sep DISC >D> AB 15MG A 200822 005 Jul 15, 2013 Sep DISC >A> @ 15MG A 200822 005 Jul 15, 2013 Sep DISC >D> AB 20MG A 200822 006 Jul 15, 2013 Sep DISC >A> @ 20MG A 200822 006 Jul 15, 2013 Sep DISC >D> AB 30MG A 200822 007 Jul 15, 2013 Sep DISC >A> @ 30MG A 200822 007 Jul 15, 2013 Sep DISC >D> AB 40MG A 200822 001 Jul 15, 2013 Sep DISC >A> @ 40MG A 200822 001 Jul 15, 2013 Sep DISC >D> AB IMPAX LABS 5MG A 079087 001 Jun 14, 2010 Sep CTEC >A> 5MG A 079087 001 Jun 14, 2010 Sep CTEC >D> AB 7.5MG A 079087 002 Dec 21, 2010 Sep CTEC >A> 7.5MG A 079087 002 Dec 21, 2010 Sep CTEC >D> AB 10MG A 079087 003 Jun 14, 2010 Sep CTEC >A> 10MG A 079087 003 Jun 14, 2010 Sep CTEC >D> AB 15MG A 079087 004 Dec 21, 2010 Sep CTEC >A> 15MG A 079087 004 Dec 21, 2010 Sep CTEC >D> AB 20MG A 079087 005 Jun 14, 2010 Sep CTEC >A> 20MG A 079087 005 Jun 14, 2010 Sep CTEC >D> AB 30MG A 079087 006 Jul 22, 2010 Sep CTEC >A> 30MG A 079087 006 Jul 22, 2010 Sep CTEC

PENTETATE CALCIUM TRISODIUM SOLUTION;INHALATION, INTRAVENOUS PENTETATE CALCIUM TRISODIUM >A> + @ HAMELN EQ 1GM BASE/5ML (EQ 200MG N 021749 001 Aug 11, 2004 Sep DISC BASE/ML) >A> + @ EQ 1GM BASE/5ML (EQ 200MG N 021749 001 Aug 11, 2004 Sep DISC BASE/ML) >D> +! HAMELN PHARMA PLUS EQ 1GM BASE/5ML (EQ 200MG N 021749 001 Aug 11, 2004 Sep DISC BASE/ML)

>D> PENTETATE TRISODIUM >D> SOLUTION;INHALATION, INTRAVENOUS >D> PENTETATE ZINC TRISODIUM >D> +! HAMELN PHARMA PLUS EQ 1GM BASE/5ML (EQ 200MG N 021751 001 Aug 11, 2004 Sep DISC BASE/ML) >A> + @ EQ 1GM BASE/5ML (EQ 200MG N 021751 001 Aug 11, 2004 Sep DISC BASE/ML)

Page 23 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PILOCARPINE HYDROCHLORIDE SOLUTION;OPHTHALMIC PILOCARPINE HYDROCHLORIDE >A> AT AMNEAL 1% A 214193 001 Sep 21, 2020 Sep NEWA >A> AT 2% A 214193 002 Sep 21, 2020 Sep NEWA >A> AT 4% A 214193 003 Sep 21, 2020 Sep NEWA TABLET;ORAL PILOCARPINE HYDROCHLORIDE >D> AB INNOGENIX 5MG A 076963 001 Dec 22, 2004 Sep CAHN >D> AB 7.5MG A 076963 002 Feb 27, 2007 Sep CAHN >A> AB MLV 5MG A 076963 001 Dec 22, 2004 Sep CAHN >A> AB 7.5MG A 076963 002 Feb 27, 2007 Sep CAHN

POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >D> AB1 CENTAUR PHARMS PVT 10MEQ A 213588 001 Aug 21, 2020 Sep CAHN >D> AB1 20MEQ A 213588 002 Aug 21, 2020 Sep CAHN >A> AB1 UNICHEM 10MEQ A 213588 001 Aug 21, 2020 Sep CAHN >A> AB1 20MEQ A 213588 002 Aug 21, 2020 Sep CAHN >A> AB1 ZYDUS PHARMS 10MEQ A 210395 001 Sep 17, 2020 Sep NEWA >A> AB1 20MEQ A 210395 002 Sep 17, 2020 Sep NEWA

POTASSIUM CHLORIDE; SODIUM CHLORIDE INJECTABLE;INJECTION POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 150MG/100ML;450MG/100ML A 212347 001 Sep 17, 2020 Sep NEWA POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 300MG/100ML;900MG/100ML A 212347 002 Sep 17, 2020 Sep NEWA

PRALIDOXIME CHLORIDE SOLUTION;INTRAMUSCULAR >D> PRALIDOXIME CHLORIDE (AUTOINJECTOR) >D> +! MERIDIAN MEDCL TECHN 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Sep DISC >A> + @ 600MG/2ML (300MG/ML) N 018986 001 Apr 26, 1983 Sep DISC

>A> PRALSETINIB >A> CAPSULE;ORAL >A> GAVRETO >A> +! BLUEPRINT MEDICINES 100MG N 213721 001 Sep 04, 2020 Sep NEWA

PRASUGREL HYDROCHLORIDE TABLET;ORAL >A> AB ANDA REPOSITORY EQ 5MG BASE A 205790 001 Oct 16, 2017 Sep CAHN >A> AB EQ 10MG BASE A 205790 002 Oct 16, 2017 Sep CAHN >D> AB USPHARMA WINDLAS EQ 5MG BASE A 205790 001 Oct 16, 2017 Sep CAHN >D> AB EQ 10MG BASE A 205790 002 Oct 16, 2017 Sep CAHN

PRAVASTATIN SODIUM TABLET;ORAL PRAVASTATIN SODIUM >D> AB APPCO 10MG A 209869 001 Apr 13, 2018 Sep CAHN >D> AB 20MG A 209869 002 Apr 13, 2018 Sep CAHN >D> AB 40MG A 209869 003 Apr 13, 2018 Sep CAHN >D> AB 80MG A 209869 004 Apr 13, 2018 Sep CAHN >A> AB BIOCON PHARMA 10MG A 209869 001 Apr 13, 2018 Sep CAHN >A> AB 20MG A 209869 002 Apr 13, 2018 Sep CAHN >A> AB 40MG A 209869 003 Apr 13, 2018 Sep CAHN >A> AB 80MG A 209869 004 Apr 13, 2018 Sep CAHN >D> AB ZYDUS PHARMS USA 10MG A 077751 001 Apr 30, 2008 Sep DISC >A> @ 10MG A 077751 001 Apr 30, 2008 Sep DISC

PREDNISONE TABLET;ORAL >D> AB HIKMA PHARMS 50MG A 088465 001 Jun 01, 1984 Sep DISC >A> @ 50MG A 088465 001 Jun 01, 1984 Sep DISC

Page 24 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PRIMIDONE TABLET;ORAL PRIMIDONE >D> AB HIKMA INTL PHARMS 250MG A 040667 002 Jul 27, 2006 Sep DISC >A> @ 250MG A 040667 002 Jul 27, 2006 Sep DISC

PROGESTERONE >D> SYSTEM;VAGINAL >D> MILPROSA >D> +! FERRING PHARMS INC 1.78GM N 201110 001 Apr 29, 2020 Sep DISC >A> + @ 1.78GM N 201110 001 Apr 29, 2020 Sep DISC

PROPOFOL INJECTABLE;INJECTION >A> AB INNOPHARMA 10MG/ML A 205576 001 Sep 16, 2020 Sep NEWA

PROPRANOLOL HYDROCHLORIDE TABLET;ORAL PROPRANOLOL HYDROCHLORIDE >D> AB ! IMPAX LABS INC 80MG A 071976 001 Apr 06, 1988 Sep DISC >A> @ 80MG A 071976 001 Apr 06, 1988 Sep DISC >D> AB WATSON LABS 80MG A 070178 001 May 13, 1986 Sep CHRS >A> AB ! 80MG A 070178 001 May 13, 1986 Sep CHRS

PYRIDOSTIGMINE BROMIDE SYRUP;ORAL PYRIDOSTIGMINE BROMIDE >A> AA ELYSIUM 60MG/5ML A 208797 001 Jan 09, 2020 Sep CAHN >D> AA INVATECH 60MG/5ML A 208797 001 Jan 09, 2020 Sep CAHN TABLET;ORAL PYRIDOSTIGMINE BROMIDE >D> ELYSIUM 30MG A 211181 002 May 14, 2019 Sep CAHN >D> AB 60MG A 211181 001 Jul 20, 2018 Sep CAHN >A> EYWA 30MG A 211181 002 May 14, 2019 Sep CAHN >A> AB 60MG A 211181 001 Jul 20, 2018 Sep CAHN

RANITIDINE HYDROCHLORIDE TABLET;ORAL RANITIDINE HYDROCHLORIDE >D> AB NOSTRUM LABS INC EQ 150MG BASE A 203694 001 Nov 30, 2017 Sep DISC >A> @ EQ 150MG BASE A 203694 001 Nov 30, 2017 Sep DISC >D> AB EQ 300MG BASE A 203694 002 Nov 30, 2017 Sep DISC >A> @ EQ 300MG BASE A 203694 002 Nov 30, 2017 Sep DISC

RANOLAZINE TABLET, EXTENDED RELEASE;ORAL RANOLAZINE >D> AB SUNGEN PHARMA 500MG A 212781 001 Mar 23, 2020 Sep DISC >A> @ 500MG A 212781 001 Mar 23, 2020 Sep DISC >D> AB 1GM A 212781 002 Mar 23, 2020 Sep DISC >A> @ 1GM A 212781 002 Mar 23, 2020 Sep DISC

RISPERIDONE TABLET;ORAL RISPERIDONE >D> AB MYLAN 0.5MG A 076288 002 Sep 15, 2008 Sep DISC >A> @ 0.5MG A 076288 002 Sep 15, 2008 Sep DISC >D> AB 1MG A 076288 003 Sep 15, 2008 Sep DISC >A> @ 1MG A 076288 003 Sep 15, 2008 Sep DISC >D> AB 2MG A 076288 004 Sep 15, 2008 Sep DISC >A> @ 2MG A 076288 004 Sep 15, 2008 Sep DISC >D> AB 3MG A 076288 005 Sep 15, 2008 Sep DISC >A> @ 3MG A 076288 005 Sep 15, 2008 Sep DISC >D> AB 4MG A 076288 006 Sep 15, 2008 Sep DISC >A> @ 4MG A 076288 006 Sep 15, 2008 Sep DISC

Page 25 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RIZATRIPTAN BENZOATE TABLET;ORAL RIZATRIPTAN BENZOATE >D> AB ECI PHARMS LLC EQ 5MG BASE A 202047 001 Dec 31, 2012 Sep CAHN >D> AB EQ 10MG BASE A 202047 002 Dec 31, 2012 Sep CAHN >A> AB PHARMA LIFE EQ 5MG BASE A 202047 001 Dec 31, 2012 Sep CAHN >A> AB EQ 10MG BASE A 202047 002 Dec 31, 2012 Sep CAHN

ROCURONIUM BROMIDE INJECTABLE;INJECTION ROCURONIUM BROMIDE >A> AP PIRAMAL CRITICAL 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Sep CAHN >A> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Sep CAHN >D> AP SANOVEL ILAC 50MG/5ML (10MG/ML) A 210437 001 Aug 13, 2019 Sep CAHN >D> AP 100MG/10ML (10MG/ML) A 210437 002 Aug 13, 2019 Sep CAHN

ROMIDEPSIN SOLUTION;INTRAVENOUS ROMIDEPSIN >D> + TEVA PHARMS USA INC 10MG/2ML (5MG/ML) N 208574 001 Mar 13, 2020 Sep DISC >A> + @ 10MG/2ML (5MG/ML) N 208574 001 Mar 13, 2020 Sep DISC

ROPIVACAINE HYDROCHLORIDE SOLUTION;INJECTION ROPIVACAINE HYDROCHLORIDE >D> AP MYLAN ASI 40MG/20ML (2MG/ML) A 090318 001 Sep 23, 2014 Sep DISC >A> @ 40MG/20ML (2MG/ML) A 090318 001 Sep 23, 2014 Sep DISC >D> AP 150MG/20ML (7.5MG/ML) A 090318 003 Sep 23, 2014 Sep DISC >A> @ 150MG/20ML (7.5MG/ML) A 090318 003 Sep 23, 2014 Sep DISC

ROSUVASTATIN CALCIUM TABLET;ORAL CALCIUM >A> AB LUPIN 5MG A 205587 001 Jul 31, 2017 Sep CAHN >A> AB 10MG A 205587 002 Jul 31, 2017 Sep CAHN >A> AB 20MG A 205587 003 Jul 31, 2017 Sep CAHN >A> AB 40MG A 205587 004 Jul 31, 2017 Sep CAHN >D> AB LUPIN LTD 5MG A 205587 001 Jul 31, 2017 Sep CAHN >D> AB 10MG A 205587 002 Jul 31, 2017 Sep CAHN >D> AB 20MG A 205587 003 Jul 31, 2017 Sep CAHN >D> AB 40MG A 205587 004 Jul 31, 2017 Sep CAHN

SEVELAMER CARBONATE TABLET;ORAL SEVELAMER CARBONATE >D> AB ANXIN 800MG A 212970 001 Apr 09, 2020 Sep DISC >A> @ 800MG A 212970 001 Apr 09, 2020 Sep DISC >A> AB INDICUS PHARMA 800MG A 204451 001 Nov 29, 2018 Sep CAHN >D> AB WILSHIRE PHARMS INC 800MG A 204451 001 Nov 29, 2018 Sep CAHN

SILDENAFIL CITRATE TABLET;ORAL SILDENAFIL CITRATE >D> AB HEBEI CHANGSHAN EQ 20MG BASE A 202598 001 Nov 06, 2012 Sep CAHN >A> AB YILING EQ 20MG BASE A 202598 001 Nov 06, 2012 Sep CAHN

SODIUM IODIDE I-131 CAPSULE;ORAL SODIUM IODIDE I 131 >A> + JUBILANT 0.009-0.1mCi N 021305 006 May 19, 2005 Sep CAHN >A> @ 2-200mCi N 021305 004 Nov 18, 2004 Sep CAHN >D> + JUBILANT DRAXIMAGE 0.009-0.1mCi N 021305 006 May 19, 2005 Sep CAHN >D> @ 2-200mCi N 021305 004 Nov 18, 2004 Sep CAHN SOLUTION;ORAL HICON >A> @ JUBILANT 1-250mCi/0.25ML N 021305 002 Jan 24, 2003 Sep CAHN >A> @ 1-500mCi/0.5ML N 021305 003 Jan 24, 2003 Sep CAHN >A> @ 1-1000mCi/ML N 021305 005 Apr 04, 2006 Sep CAHN >A> AA +! 250-1000mCi N 021305 007 Dec 05, 2011 Sep CAHN >D> @ JUBILANT DRAXIMAGE 1-250mCi/0.25ML N 021305 002 Jan 24, 2003 Sep CAHN

Page 26 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

SODIUM IODIDE I-131 SOLUTION;ORAL HICON >D> @ 1-500mCi/0.5ML N 021305 003 Jan 24, 2003 Sep CAHN >D> @ 1-1000mCi/ML N 021305 005 Apr 04, 2006 Sep CAHN >D> AA +! 250-1000mCi N 021305 007 Dec 05, 2011 Sep CAHN

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE >D> AP CAPLIN 25MG/ML A 211016 001 Nov 29, 2019 Sep CAHN >A> AP HONG KONG 25MG/ML A 211016 001 Nov 29, 2019 Sep CAHN

SODIUM OXYBATE SOLUTION;ORAL >D> SODIUM OXYBATE >D> AA HIKMA 0.5GM/ML A 202090 001 Jan 17, 2017 Sep DISC >A> @ 0.5GM/ML A 202090 001 Jan 17, 2017 Sep DISC XYREM >D> AA +! JAZZ PHARMS 0.5GM/ML N 021196 001 Jul 17, 2002 Sep CTEC >A> +! 0.5GM/ML N 021196 001 Jul 17, 2002 Sep CTEC

SODIUM POLYSTYRENE SULFONATE POWDER;ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE >A> AA DISCOVERY THERAP 453.6GM/BOT A 090313 001 Dec 21, 2011 Sep CAHN >D> AA ECI PHARMS LLC 453.6GM/BOT A 090313 001 Dec 21, 2011 Sep CAHN

SORAFENIB TOSYLATE TABLET;ORAL NEXAVAR >D> +! BAYER HLTHCARE EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CFTG >A> AB +! EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CFTG >A> +! EQ 200MG BASE N 021923 001 Dec 20, 2005 Sep CTEC SORAFENIB TOSYLATE >A> @ MYLAN EQ 200MG BASE A 207012 001 Sep 10, 2020 Sep DISC >A> AB EQ 200MG BASE A 207012 001 Sep 10, 2020 Sep NFTG

STAVUDINE CAPSULE;ORAL STAVUDINE >D> AB AUROBINDO PHARMA 15MG A 077672 003 Dec 29, 2008 Sep CTEC >A> 15MG A 077672 003 Dec 29, 2008 Sep CTEC >D> AB 20MG A 077672 004 Dec 29, 2008 Sep CTEC >A> 20MG A 077672 004 Dec 29, 2008 Sep CTEC >D> AB 30MG A 077672 001 Dec 29, 2008 Sep CTEC >A> 30MG A 077672 001 Dec 29, 2008 Sep CTEC >D> AB 40MG A 077672 002 Dec 29, 2008 Sep CHRS >A> AB ! 40MG A 077672 002 Dec 29, 2008 Sep CHRS >A> ! 40MG A 077672 002 Dec 29, 2008 Sep CTEC >D> ZERIT >D> AB + BRISTOL MYERS SQUIBB 15MG N 020412 002 Jun 24, 1994 Sep DISC >D> AB + 20MG N 020412 003 Jun 24, 1994 Sep DISC >D> AB + 30MG N 020412 004 Jun 24, 1994 Sep DISC >D> AB +! 40MG N 020412 005 Jun 24, 1994 Sep DISC >A> + @ BRISTOL-MYERS SQUIBB 15MG N 020412 002 Jun 24, 1994 Sep DISC >A> + @ 20MG N 020412 003 Jun 24, 1994 Sep DISC >A> + @ 30MG N 020412 004 Jun 24, 1994 Sep DISC >A> + @ 40MG N 020412 005 Jun 24, 1994 Sep DISC

SUMATRIPTAN SPRAY;NASAL SUMATRIPTAN >A> AB PERRIGO UK FINCO 5MG/SPRAY A 213650 001 Sep 21, 2020 Sep NEWA >A> AB 20MG/SPRAY A 213465 001 Sep 21, 2020 Sep NEWA

Page 27 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TAMOXIFEN CITRATE >D> SOLUTION;ORAL >D> SOLTAMOX >D> FORTOVIA EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Sep DISC >A> @ EQ 20MG BASE/10ML N 021807 001 Oct 29, 2005 Sep DISC

TECHNETIUM TC-99M EXAMETAZIME KIT POWDER;INTRAVENOUS DRAX EXAMETAZIME >A> JUBILANT N/A N 208870 001 Aug 17, 2017 Sep CAHN >D> JUBILANT DRAXIMAGE N/A N 208870 001 Aug 17, 2017 Sep CAHN

TECHNETIUM TC-99M MEDRONATE INJECTABLE;INJECTION DRAXIMAGE MDP-10 >A> @ JUBILANT N/A N 018035 001 Nov 28, 1978 Sep CAHN >D> @ JUBILANT DRAXIMAGE N/A N 018035 001 Nov 28, 1978 Sep CAHN DRAXIMAGE MDP-25 >A> +! JUBILANT N/A N 018035 002 Feb 27, 2004 Sep CAHN >D> +! JUBILANT DRAXIMAGE N/A N 018035 002 Feb 27, 2004 Sep CAHN

TELOTRISTAT ETIPRATE TABLET;ORAL XERMELO >D> +! LEXICON PHARMS INC EQ 250MG BASE N 208794 001 Feb 28, 2017 Sep CAHN >A> +! TERSERA EQ 250MG BASE N 208794 001 Feb 28, 2017 Sep CAHN

TEMOZOLOMIDE CAPSULE;ORAL TEMOZOLOMIDE >D> AB AMERIGEN PHARMS LTD 5MG A 203490 001 Jul 13, 2016 Sep CAHN >D> AB 20MG A 203490 002 Jul 13, 2016 Sep CAHN >D> AB 100MG A 203490 003 Jul 13, 2016 Sep CAHN >D> AB 140MG A 203490 004 Jul 13, 2016 Sep CAHN >D> AB 180MG A 203490 005 Jul 13, 2016 Sep CAHN >D> AB 250MG A 203490 006 Jul 13, 2016 Sep CAHN >A> AB ANI PHARMS INC 5MG A 203490 001 Jul 13, 2016 Sep CAHN >A> AB 20MG A 203490 002 Jul 13, 2016 Sep CAHN >A> AB 100MG A 203490 003 Jul 13, 2016 Sep CAHN >A> AB 140MG A 203490 004 Jul 13, 2016 Sep CAHN >A> AB 180MG A 203490 005 Jul 13, 2016 Sep CAHN >A> AB 250MG A 203490 006 Jul 13, 2016 Sep CAHN

TERAZOSIN HYDROCHLORIDE CAPSULE;ORAL TERAZOSIN HYDROCHLORIDE >D> AB APNAR PHARMA LP EQ 1MG BASE A 074823 001 Mar 30, 1998 Sep CHRS >A> AB ! EQ 1MG BASE A 074823 001 Mar 30, 1998 Sep CHRS >D> AB ! EQ 2MG BASE A 074823 002 Mar 30, 1998 Sep CHRS >A> AB EQ 2MG BASE A 074823 002 Mar 30, 1998 Sep CHRS >D> AB HIKMA EQ 1MG BASE A 075498 001 Apr 12, 2001 Sep DISC >A> @ EQ 1MG BASE A 075498 001 Apr 12, 2001 Sep DISC >D> AB EQ 2MG BASE A 075498 002 Apr 12, 2001 Sep DISC >A> @ EQ 2MG BASE A 075498 002 Apr 12, 2001 Sep DISC >D> AB EQ 5MG BASE A 075498 003 Apr 12, 2001 Sep DISC >A> @ EQ 5MG BASE A 075498 003 Apr 12, 2001 Sep DISC >D> AB EQ 10MG BASE A 075498 004 Apr 12, 2001 Sep DISC >A> @ EQ 10MG BASE A 075498 004 Apr 12, 2001 Sep DISC

TETRACYCLINE HYDROCHLORIDE CAPSULE;ORAL TETRACYCLINE HYDROCHLORIDE >D> @ STRIDES PHARMA 250MG A 212635 001 Mar 03, 2020 Sep CMFD >A> AB 250MG A 212635 001 Mar 03, 2020 Sep CMFD >D> @ 500MG A 212635 002 Mar 03, 2020 Sep CMFD >A> AB 500MG A 212635 002 Mar 03, 2020 Sep CMFD

Page 28 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TICAGRELOR TABLET;ORAL >A> @ AMNEAL 90MG A 208531 001 Jan 23, 2019 Sep CAHN >D> @ AMNEAL PHARMS CO 90MG A 208531 001 Jan 23, 2019 Sep CAHN >D> AB HEC PHARM CO LTD 90MG A 208508 001 Apr 06, 2020 Sep CAHN >A> AB SUNSHINE 90MG A 208508 001 Apr 06, 2020 Sep CAHN

TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC >A> TIMOLOL MALEATE >A> AT3 AKORN INC EQ 0.5% BASE A 212291 001 Sep 11, 2020 Sep NFTG TIMOPTIC IN OCUDOSE >D> +! VALEANT PHARMS INTL EQ 0.5% BASE N 019463 002 Nov 05, 1986 Sep CFTG >A> AT3 +! EQ 0.5% BASE N 019463 002 Nov 05, 1986 Sep CFTG

TOBRAMYCIN SOLUTION;INHALATION BETHKIS >D> +! CHIESI 300MG/4ML N 201820 001 Oct 12, 2012 Sep CTEC >A> AN +! 300MG/4ML N 201820 001 Oct 12, 2012 Sep CTEC

TOFACITINIB CITRATE >A> SOLUTION;ORAL >A> Xeljanz >A> +! PFIZER EQ 1MG/ML BASE N 213082 001 Sep 25, 2020 Sep NEWA

TOLTERODINE TARTRATE TABLET;ORAL TOLTERODINE TARTRATE >A> AB ATHEM 1MG A 210775 001 Dec 30, 2019 Sep CAHN >A> AB 2MG A 210775 002 Dec 30, 2019 Sep CAHN >D> AB INVATECH 1MG A 210775 001 Dec 30, 2019 Sep CAHN >D> AB 2MG A 210775 002 Dec 30, 2019 Sep CAHN

TRAMADOL HYDROCHLORIDE >A> SOLUTION;ORAL >A> QDOLO >A> +! ATHENA 5MG/ML N 214044 001 Sep 01, 2020 Sep NEWA

TRIFLUOPERAZINE HYDROCHLORIDE TABLET;ORAL TRIFLUOPERAZINE HYDROCHLORIDE >A> @ ATHEM EQ 1MG BASE A 040153 001 Oct 25, 1996 Sep CAHN >A> @ EQ 2MG BASE A 040153 002 Oct 25, 1996 Sep CAHN >A> @ EQ 5MG BASE A 040153 003 Oct 25, 1996 Sep CAHN >A> @ EQ 10MG BASE A 040153 004 Oct 25, 1996 Sep CAHN >D> @ INVATECH EQ 1MG BASE A 040153 001 Oct 25, 1996 Sep CAHN >D> @ EQ 2MG BASE A 040153 002 Oct 25, 1996 Sep CAHN >D> @ EQ 5MG BASE A 040153 003 Oct 25, 1996 Sep CAHN >D> @ EQ 10MG BASE A 040153 004 Oct 25, 1996 Sep CAHN

VALACYCLOVIR HYDROCHLORIDE TABLET;ORAL VALACYCLOVIR HYDROCHLORIDE >D> AB HIKMA EQ 500MG BASE A 078656 001 May 24, 2010 Sep DISC >A> @ EQ 500MG BASE A 078656 001 May 24, 2010 Sep DISC >D> AB EQ 1GM BASE A 078656 002 May 24, 2010 Sep DISC >A> @ EQ 1GM BASE A 078656 002 May 24, 2010 Sep DISC

VALGANCICLOVIR HYDROCHLORIDE FOR SOLUTION;ORAL VALGANCICLOVIR HYDROCHLORIDE >D> AB GRANULES PHARMS 50MG/ML A 213306 001 Jan 31, 2020 Sep DISC >A> @ 50MG/ML A 213306 001 Jan 31, 2020 Sep DISC

Page 29 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VALPROIC ACID CAPSULE;ORAL VALPROIC ACID >A> AB EYWA 250MG A 207611 001 Aug 05, 2019 Sep CAHN >D> AB NOVELGENIX THERAPS 250MG A 207611 001 Aug 05, 2019 Sep CAHN SYRUP;ORAL VALPROIC ACID >A> AA BIOPHARM 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN >D> AA ECI PHARMS LLC 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN >A> AA PHARMA LIFE 250MG/5ML A 090517 001 May 28, 2010 Sep CAHN

VANCOMYCIN HYDROCHLORIDE INJECTABLE;INJECTION HYDROCHLORIDE >A> AP HOSPIRA EQ 10GM BASE/VIAL A 063076 002 Sep 14, 2020 Sep NEWA

VARDENAFIL HYDROCHLORIDE TABLET;ORAL LEVITRA >D> + @ BAYER HLTHCARE 2.5MG N 021400 003 Aug 19, 2003 Sep CPOT >A> + @ EQ 2.5MG BASE N 021400 003 Aug 19, 2003 Sep CPOT >D> AB + 5MG N 021400 001 Aug 19, 2003 Sep CPOT >A> AB + EQ 5MG BASE N 021400 001 Aug 19, 2003 Sep CPOT >D> AB + 10MG N 021400 002 Aug 19, 2003 Sep CPOT >A> AB + EQ 10MG BASE N 021400 002 Aug 19, 2003 Sep CPOT >D> AB +! 20MG N 021400 004 Aug 19, 2003 Sep CPOT >A> AB +! EQ 20MG BASE N 021400 004 Aug 19, 2003 Sep CPOT VARDENAFIL HYDROCHLORIDE >D> AB ALEMBIC PHARMS LTD 2.5MG A 214031 001 Aug 04, 2020 Sep CPOT >A> AB EQ 2.5MG BASE A 214031 001 Aug 04, 2020 Sep CPOT >D> AB 5MG A 214031 002 Aug 04, 2020 Sep CPOT >A> AB EQ 5MG BASE A 214031 002 Aug 04, 2020 Sep CPOT >D> AB 10MG A 214031 003 Aug 04, 2020 Sep CPOT >A> AB EQ 10MG BASE A 214031 003 Aug 04, 2020 Sep CPOT >D> AB 20MG A 214031 004 Aug 04, 2020 Sep CPOT >A> AB EQ 20MG BASE A 214031 004 Aug 04, 2020 Sep CPOT >D> @ AMNEAL PHARMS CO 5MG A 210738 001 Oct 31, 2018 Sep CPOT >A> @ EQ 5MG BASE A 210738 001 Oct 31, 2018 Sep CPOT >D> @ 10MG A 210738 002 Oct 31, 2018 Sep CPOT >A> @ EQ 10MG BASE A 210738 002 Oct 31, 2018 Sep CPOT >D> @ 20MG A 210738 003 Oct 31, 2018 Sep CPOT >A> @ EQ 20MG BASE A 210738 003 Oct 31, 2018 Sep CPOT >D> AB CROSSMEDIKA SA 2.5MG A 209057 001 Oct 31, 2018 Sep CPOT >A> AB EQ 2.5MG BASE A 209057 001 Oct 31, 2018 Sep CPOT >D> AB 5MG A 209057 002 Oct 31, 2018 Sep CPOT >A> AB EQ 5MG BASE A 209057 002 Oct 31, 2018 Sep CPOT >D> AB 10MG A 209057 003 Oct 31, 2018 Sep CPOT >A> AB EQ 10MG BASE A 209057 003 Oct 31, 2018 Sep CPOT >D> AB 20MG A 209057 004 Oct 31, 2018 Sep CPOT >A> AB EQ 20MG BASE A 209057 004 Oct 31, 2018 Sep CPOT >D> AB MACLEODS PHARMS LTD 2.5MG A 204632 001 Oct 22, 2019 Sep CPOT >A> AB EQ 2.5MG BASE A 204632 001 Oct 22, 2019 Sep CPOT >D> AB 5MG A 204632 002 Oct 22, 2019 Sep CPOT >A> AB EQ 5MG BASE A 204632 002 Oct 22, 2019 Sep CPOT >D> AB 10MG A 204632 003 Oct 22, 2019 Sep CPOT >A> AB EQ 10MG BASE A 204632 003 Oct 22, 2019 Sep CPOT >D> AB 20MG A 204632 004 Oct 22, 2019 Sep CPOT >A> AB EQ 20MG BASE A 204632 004 Oct 22, 2019 Sep CPOT >D> AB TEVA PHARMS 2.5MG A 091347 001 May 03, 2012 Sep CPOT >A> AB EQ 2.5MG BASE A 091347 001 May 03, 2012 Sep CPOT >D> AB 5MG A 091347 002 May 03, 2012 Sep CPOT >A> AB EQ 5MG BASE A 091347 002 May 03, 2012 Sep CPOT >D> AB 10MG A 091347 003 May 03, 2012 Sep CPOT >A> AB EQ 10MG BASE A 091347 003 May 03, 2012 Sep CPOT >D> AB 20MG A 091347 004 May 03, 2012 Sep CPOT >A> AB EQ 20MG BASE A 091347 004 May 03, 2012 Sep CPOT >D> AB ZYDUS PHARMS 2.5MG A 208960 001 Oct 31, 2018 Sep CPOT >A> AB EQ 2.5MG BASE A 208960 001 Oct 31, 2018 Sep CPOT >D> AB 5MG A 208960 002 Oct 31, 2018 Sep CPOT

Page 30 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VARDENAFIL HYDROCHLORIDE TABLET;ORAL VARDENAFIL HYDROCHLORIDE >A> AB EQ 5MG BASE A 208960 002 Oct 31, 2018 Sep CPOT >D> AB 10MG A 208960 003 Oct 31, 2018 Sep CPOT >A> AB EQ 10MG BASE A 208960 003 Oct 31, 2018 Sep CPOT >D> AB 20MG A 208960 004 Oct 31, 2018 Sep CPOT >A> AB EQ 20MG BASE A 208960 004 Oct 31, 2018 Sep CPOT

VERAPAMIL HYDROCHLORIDE INJECTABLE;INJECTION VERAPAMIL HYDROCHLORIDE >D> AUROBINDO PHARMA LTD 2.5MG/ML A 212965 001 Jul 06, 2020 Sep CHRS >A> ! 2.5MG/ML A 212965 001 Jul 06, 2020 Sep CHRS SOLUTION;INTRAVENOUS VERAPAMIL HYDROCHLORIDE >A> AP AREVA PHARMS 5MG/2ML (2.5MG/ML) A 213352 002 Sep 16, 2020 Sep NEWA

WARFARIN SODIUM TABLET;ORAL COUMADIN >D> AB + BRISTOL MYERS SQUIBB 1MG N 009218 022 Mar 01, 1990 Sep DISC >A> + @ 1MG N 009218 022 Mar 01, 1990 Sep DISC >D> AB + 2MG N 009218 013 Jan 07, 1959 Sep DISC >A> + @ 2MG N 009218 013 Jan 07, 1959 Sep DISC >D> AB + 2.5MG N 009218 018 Nov 29, 1961 Sep DISC >A> + @ 2.5MG N 009218 018 Nov 29, 1961 Sep DISC >D> AB + 3MG N 009218 025 Nov 18, 1996 Sep DISC >A> + @ 3MG N 009218 025 Nov 18, 1996 Sep DISC >D> AB + 4MG N 009218 023 Aug 24, 1993 Sep DISC >A> + @ 4MG N 009218 023 Aug 24, 1993 Sep DISC >D> AB + 5MG N 009218 007 Feb 17, 1964 Sep DISC >A> + @ 5MG N 009218 007 Feb 17, 1964 Sep DISC >D> AB + 6MG N 009218 026 Nov 18, 1996 Sep DISC >A> + @ 6MG N 009218 026 Nov 18, 1996 Sep DISC >D> AB + 7.5MG N 009218 016 Feb 16, 1960 Sep DISC >A> + @ 7.5MG N 009218 016 Feb 16, 1960 Sep DISC >D> AB +! 10MG N 009218 005 Nov 04, 1955 Sep DISC >A> + @ 10MG N 009218 005 Nov 04, 1955 Sep DISC SODIUM >D> AB PLIVA 10MG A 040616 008 Jul 05, 2006 Sep CHRS >A> AB ! 10MG A 040616 008 Jul 05, 2006 Sep CHRS

ZAFIRLUKAST TABLET;ORAL >A> AB ANNORA PHARMA 10MG A 212475 001 Sep 10, 2020 Sep NEWA >A> AB 20MG A 212475 002 Sep 10, 2020 Sep NEWA

ZALEPLON CAPSULE;ORAL ZALEPLON >D> AB HIKMA 5MG A 078147 001 Nov 25, 2008 Sep DISC >D> AB 10MG A 078147 002 Nov 25, 2008 Sep DISC >A> @ HIKMA PHARMS 5MG A 078147 001 Nov 25, 2008 Sep DISC >A> @ 10MG A 078147 002 Nov 25, 2008 Sep DISC

ZIDOVUDINE TABLET;ORAL ZIDOVUDINE >D> AB HIKMA 300MG A 076844 001 Sep 19, 2005 Sep DISC >A> @ 300MG A 076844 001 Sep 19, 2005 Sep DISC

ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE;ORAL ZOLPIDEM TARTRATE >A> AB BRECKENRIDGE 6.25MG A 213592 001 Jun 04, 2020 Sep CAHN >A> AB 12.5MG A 213592 002 Jun 04, 2020 Sep CAHN >D> AB CENTAUR PHARMS PVT 6.25MG A 213592 001 Jun 04, 2020 Sep CAHN >D> AB 12.5MG A 213592 002 Jun 04, 2020 Sep CAHN

Page 31 of 33 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

CETIRIZINE HYDROCHLORIDE CAPSULE;ORAL CETIRIZINE HYDROCHLORIDE ALLERGY >A> CATALENT 10MG A 213105 001 Sep 21, 2020 Sep NEWA TABLET, ORALLY DISINTEGRATING;ORAL CETIRIZINE HYDROCHLORIDE >A> AUROBINDO PHARMA LTD 10MG A 213557 001 Sep 11, 2020 Sep NEWA

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM TABLET;ORAL NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE >A> GRANULES 25MG;220MG A 213663 001 Sep 24, 2020 Sep NEWA

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE >D> AUROBINDO PHARMA LTD 600MG;60MG A 213203 001 Mar 25, 2020 Sep DISC >A> @ 600MG;60MG A 213203 001 Mar 25, 2020 Sep DISC >D> 1.2GM;120MG A 213203 002 Mar 25, 2020 Sep DISC >A> @ 1.2GM;120MG A 213203 002 Mar 25, 2020 Sep DISC

IBUPROFEN TABLET;ORAL IBUPROFEN >A> SHANDONG XINHUA 200MG A 207095 002 Aug 21, 2018 Sep CMS1

KETOTIFEN FUMARATE SOLUTION/DROPS;OPHTHALMIC ALAWAY >A> BAUSCH EQ 0.035% BASE A 208158 001 Sep 24, 2020 Sep NEWA

LORATADINE TABLET, ORALLY DISINTEGRATING;ORAL ALAVERT >A> FDN CONSUMER 10MG N 021375 001 Dec 19, 2002 Sep CAHN >D> GLAXOSMITHKLINE 10MG N 021375 001 Dec 19, 2002 Sep CAHN LORATADINE >A> RUBICON 10MG A 214280 001 Sep 10, 2020 Sep NEWA >A> TENSHI 5MG A 212795 001 Sep 18, 2020 Sep NEWA

OMEPRAZOLE; SODIUM BICARBONATE CAPSULE;ORAL AND SODIUM BICARBONATE >D> @ ACTAVIS ELIZABETH 20MG;1.1GM A 204137 001 Jul 15, 2016 Sep CAHN >D> PAR PHARM 20MG;1.1GM A 201946 001 Jul 15, 2016 Sep DISC >A> @ 20MG;1.1GM A 201946 001 Jul 15, 2016 Sep DISC >A> @ UNICORN 20MG;1.1GM A 204137 001 Jul 15, 2016 Sep CAHN

Page 32 of 33 CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 33 of 33